{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "1074ce83",
   "metadata": {},
   "source": [
    "# PrimeKG Case Study — Hurler Syndrome\n",
    "\n",
    "This notebook reproduces a **drug repurposing and disease exploration example** from the PrimeKG paper, focusing on the rare disease **Hurler syndrome (Mucopolysaccharidosis type I, severe form)**.\n",
    "\n",
    "It mirrors the Autism notebook workflow but adapted for Hurler syndrome:\n",
    "\n",
    "- Load **PrimeKG (kg.csv)**.\n",
    "- Filter Hurler syndrome–related disease labels (using MONDO / Orphanet IDs).\n",
    "- Summarize **Drug–Disease** associations (e.g., Enzyme Replacement Therapy with Laronidase, Hematopoietic Stem Cell Transplantation).\n",
    "- Collect connected **phenotypes, proteins, pathways, exposures**.\n",
    "- Build and visualize a **subgraph** centered on Hurler syndrome.\n",
    "- Explore **candidate drugs** via shared protein targets and pathways.\n",
    "\n",
    "---"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "1da875f0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[INFO] Imports ready.\n"
     ]
    }
   ],
   "source": [
    "# --- Parameters ---\n",
    "KG_PATH = \"kg.csv\"   # Path to PrimeKG giant component CSV\n",
    "KEYWORD = \"Hurler syndrome\"   # Disease of interest\n",
    "EGO_RADIUS = 2\n",
    "MAX_EDGES = 500_000\n",
    "\n",
    "import pandas as pd\n",
    "import networkx as nx\n",
    "import matplotlib.pyplot as plt\n",
    "from collections import defaultdict\n",
    "import time\n",
    "\n",
    "pd.set_option(\"display.max_colwidth\", 120)\n",
    "\n",
    "def t0():\n",
    "    s = time.time()\n",
    "    return lambda: f\"{time.time()-s:,.1f}s\"\n",
    "\n",
    "print(\"[INFO] Imports ready.\")\n",
    "timer = t0()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "265f4a56",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[INFO] Loading PrimeKG...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_53211/3916772075.py:2: DtypeWarning: Columns (3,8) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  kg = pd.read_csv(KG_PATH)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "          relation display_relation  x_index  x_id        x_type  x_name  \\\n",
      "0  protein_protein              ppi        0  9796  gene/protein  PHYHIP   \n",
      "1  protein_protein              ppi        1  7918  gene/protein  GPANK1   \n",
      "2  protein_protein              ppi        2  8233  gene/protein   ZRSR2   \n",
      "3  protein_protein              ppi        3  4899  gene/protein    NRF1   \n",
      "4  protein_protein              ppi        4  5297  gene/protein   PI4KA   \n",
      "\n",
      "  x_source  y_index   y_id        y_type  y_name y_source  \n",
      "0     NCBI     8889  56992  gene/protein   KIF15     NCBI  \n",
      "1     NCBI     2798   9240  gene/protein   PNMA1     NCBI  \n",
      "2     NCBI     5646  23548  gene/protein   TTC33     NCBI  \n",
      "3     NCBI    11592  11253  gene/protein  MAN1B1     NCBI  \n",
      "4     NCBI     2122   8601  gene/protein   RGS20     NCBI  \n",
      "[INFO] Done loading: 9.7s\n"
     ]
    }
   ],
   "source": [
    "print(\"[INFO] Loading PrimeKG...\")\n",
    "kg = pd.read_csv(KG_PATH)\n",
    "print(kg.head())\n",
    "print(\"[INFO] Done loading:\", timer())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "d51d9380",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[INFO] Found 188 edges involving Hurler syndrome.\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>relation</th>\n",
       "      <th>display_relation</th>\n",
       "      <th>x_index</th>\n",
       "      <th>x_id</th>\n",
       "      <th>x_type</th>\n",
       "      <th>x_name</th>\n",
       "      <th>x_source</th>\n",
       "      <th>y_index</th>\n",
       "      <th>y_id</th>\n",
       "      <th>y_type</th>\n",
       "      <th>y_name</th>\n",
       "      <th>y_source</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>389110</th>\n",
       "      <td>indication</td>\n",
       "      <td>indication</td>\n",
       "      <td>20647</td>\n",
       "      <td>DB00090</td>\n",
       "      <td>drug</td>\n",
       "      <td>Laronidase</td>\n",
       "      <td>DrugBank</td>\n",
       "      <td>28579</td>\n",
       "      <td>11758</td>\n",
       "      <td>disease</td>\n",
       "      <td>Hurler syndrome</td>\n",
       "      <td>MONDO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3097765</th>\n",
       "      <td>disease_phenotype_positive</td>\n",
       "      <td>phenotype present</td>\n",
       "      <td>28579</td>\n",
       "      <td>11758</td>\n",
       "      <td>disease</td>\n",
       "      <td>Hurler syndrome</td>\n",
       "      <td>MONDO</td>\n",
       "      <td>24291</td>\n",
       "      <td>2344</td>\n",
       "      <td>effect/phenotype</td>\n",
       "      <td>Progressive neurologic deterioration</td>\n",
       "      <td>HPO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3097766</th>\n",
       "      <td>disease_phenotype_positive</td>\n",
       "      <td>phenotype present</td>\n",
       "      <td>28579</td>\n",
       "      <td>11758</td>\n",
       "      <td>disease</td>\n",
       "      <td>Hurler syndrome</td>\n",
       "      <td>MONDO</td>\n",
       "      <td>22373</td>\n",
       "      <td>7957</td>\n",
       "      <td>effect/phenotype</td>\n",
       "      <td>Corneal opacity</td>\n",
       "      <td>HPO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3097767</th>\n",
       "      <td>disease_phenotype_positive</td>\n",
       "      <td>phenotype present</td>\n",
       "      <td>28579</td>\n",
       "      <td>11758</td>\n",
       "      <td>disease</td>\n",
       "      <td>Hurler syndrome</td>\n",
       "      <td>MONDO</td>\n",
       "      <td>22355</td>\n",
       "      <td>7759</td>\n",
       "      <td>effect/phenotype</td>\n",
       "      <td>Opacification of the corneal stroma</td>\n",
       "      <td>HPO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3097768</th>\n",
       "      <td>disease_phenotype_positive</td>\n",
       "      <td>phenotype present</td>\n",
       "      <td>28579</td>\n",
       "      <td>11758</td>\n",
       "      <td>disease</td>\n",
       "      <td>Hurler syndrome</td>\n",
       "      <td>MONDO</td>\n",
       "      <td>22304</td>\n",
       "      <td>365</td>\n",
       "      <td>effect/phenotype</td>\n",
       "      <td>Hearing impairment</td>\n",
       "      <td>HPO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3097769</th>\n",
       "      <td>disease_phenotype_positive</td>\n",
       "      <td>phenotype present</td>\n",
       "      <td>28579</td>\n",
       "      <td>11758</td>\n",
       "      <td>disease</td>\n",
       "      <td>Hurler syndrome</td>\n",
       "      <td>MONDO</td>\n",
       "      <td>85437</td>\n",
       "      <td>3311</td>\n",
       "      <td>effect/phenotype</td>\n",
       "      <td>Hypoplasia of the odontoid process</td>\n",
       "      <td>HPO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3097770</th>\n",
       "      <td>disease_phenotype_positive</td>\n",
       "      <td>phenotype present</td>\n",
       "      <td>28579</td>\n",
       "      <td>11758</td>\n",
       "      <td>disease</td>\n",
       "      <td>Hurler syndrome</td>\n",
       "      <td>MONDO</td>\n",
       "      <td>22488</td>\n",
       "      <td>4322</td>\n",
       "      <td>effect/phenotype</td>\n",
       "      <td>Short stature</td>\n",
       "      <td>HPO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3097771</th>\n",
       "      <td>disease_phenotype_positive</td>\n",
       "      <td>phenotype present</td>\n",
       "      <td>28579</td>\n",
       "      <td>11758</td>\n",
       "      <td>disease</td>\n",
       "      <td>Hurler syndrome</td>\n",
       "      <td>MONDO</td>\n",
       "      <td>23236</td>\n",
       "      <td>1371</td>\n",
       "      <td>effect/phenotype</td>\n",
       "      <td>Flexion contracture</td>\n",
       "      <td>HPO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3097772</th>\n",
       "      <td>disease_phenotype_positive</td>\n",
       "      <td>phenotype present</td>\n",
       "      <td>28579</td>\n",
       "      <td>11758</td>\n",
       "      <td>disease</td>\n",
       "      <td>Hurler syndrome</td>\n",
       "      <td>MONDO</td>\n",
       "      <td>22282</td>\n",
       "      <td>280</td>\n",
       "      <td>effect/phenotype</td>\n",
       "      <td>Coarse facial features</td>\n",
       "      <td>HPO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3097773</th>\n",
       "      <td>disease_phenotype_positive</td>\n",
       "      <td>phenotype present</td>\n",
       "      <td>28579</td>\n",
       "      <td>11758</td>\n",
       "      <td>disease</td>\n",
       "      <td>Hurler syndrome</td>\n",
       "      <td>MONDO</td>\n",
       "      <td>23151</td>\n",
       "      <td>2180</td>\n",
       "      <td>effect/phenotype</td>\n",
       "      <td>Neurodegeneration</td>\n",
       "      <td>HPO</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           relation   display_relation  x_index     x_id  \\\n",
       "389110                   indication         indication    20647  DB00090   \n",
       "3097765  disease_phenotype_positive  phenotype present    28579    11758   \n",
       "3097766  disease_phenotype_positive  phenotype present    28579    11758   \n",
       "3097767  disease_phenotype_positive  phenotype present    28579    11758   \n",
       "3097768  disease_phenotype_positive  phenotype present    28579    11758   \n",
       "3097769  disease_phenotype_positive  phenotype present    28579    11758   \n",
       "3097770  disease_phenotype_positive  phenotype present    28579    11758   \n",
       "3097771  disease_phenotype_positive  phenotype present    28579    11758   \n",
       "3097772  disease_phenotype_positive  phenotype present    28579    11758   \n",
       "3097773  disease_phenotype_positive  phenotype present    28579    11758   \n",
       "\n",
       "          x_type           x_name  x_source  y_index   y_id            y_type  \\\n",
       "389110      drug       Laronidase  DrugBank    28579  11758           disease   \n",
       "3097765  disease  Hurler syndrome     MONDO    24291   2344  effect/phenotype   \n",
       "3097766  disease  Hurler syndrome     MONDO    22373   7957  effect/phenotype   \n",
       "3097767  disease  Hurler syndrome     MONDO    22355   7759  effect/phenotype   \n",
       "3097768  disease  Hurler syndrome     MONDO    22304    365  effect/phenotype   \n",
       "3097769  disease  Hurler syndrome     MONDO    85437   3311  effect/phenotype   \n",
       "3097770  disease  Hurler syndrome     MONDO    22488   4322  effect/phenotype   \n",
       "3097771  disease  Hurler syndrome     MONDO    23236   1371  effect/phenotype   \n",
       "3097772  disease  Hurler syndrome     MONDO    22282    280  effect/phenotype   \n",
       "3097773  disease  Hurler syndrome     MONDO    23151   2180  effect/phenotype   \n",
       "\n",
       "                                       y_name y_source  \n",
       "389110                        Hurler syndrome    MONDO  \n",
       "3097765  Progressive neurologic deterioration      HPO  \n",
       "3097766                       Corneal opacity      HPO  \n",
       "3097767   Opacification of the corneal stroma      HPO  \n",
       "3097768                    Hearing impairment      HPO  \n",
       "3097769    Hypoplasia of the odontoid process      HPO  \n",
       "3097770                         Short stature      HPO  \n",
       "3097771                   Flexion contracture      HPO  \n",
       "3097772                Coarse facial features      HPO  \n",
       "3097773                     Neurodegeneration      HPO  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Filter rows where either side of the edge mentions Hurler syndrome\n",
    "kw = KEYWORD.lower()\n",
    "hurler_rows = kg[\n",
    "    (kg['x_name'].str.lower().str.contains(kw, na=False)) |\n",
    "    (kg['y_name'].str.lower().str.contains(kw, na=False))\n",
    "]\n",
    "print(f\"[INFO] Found {len(hurler_rows)} edges involving {KEYWORD}.\")\n",
    "hurler_rows.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "2bfdd63d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[INFO] Subgraph size: 6831 nodes, 159944 edges.\n"
     ]
    }
   ],
   "source": [
    "# Build ego-subgraph around Hurler syndrome\n",
    "G = nx.from_pandas_edgelist(kg, source=\"x_name\", target=\"y_name\", edge_attr=True)\n",
    "\n",
    "if KEYWORD in G:\n",
    "    H = nx.ego_graph(G, KEYWORD, radius=EGO_RADIUS)\n",
    "    print(f\"[INFO] Subgraph size: {len(H.nodes)} nodes, {len(H.edges)} edges.\")\n",
    "else:\n",
    "    print(\"[WARN] Disease node not found in KG. Check disease naming (MONDO/Orphanet IDs).\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "b09300df",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[INFO] Node type distribution in subgraph:\n",
      "  Norfloxacin: 1\n",
      "  Prader-Willi-like: 2\n",
      "  DDIT4: 1\n",
      "  intellectual: 71\n",
      "  obsolete: 15\n",
      "  Synovial: 1\n",
      "  Pentoxifylline: 1\n",
      "  Nepafenac: 1\n",
      "  early-onset: 12\n",
      "  spinocerebellar: 4\n",
      "  ring: 10\n",
      "  ATG5: 1\n",
      "  caudal: 2\n",
      "  persistent: 3\n",
      "  agenesis: 4\n",
      "  granulomatous: 4\n",
      "  trisomy: 15\n",
      "  myotonic: 2\n",
      "  Zolpidem: 1\n",
      "  connective: 3\n",
      "  Ito: 1\n",
      "  Menkes: 1\n",
      "  X-linked: 73\n",
      "  Bietti: 1\n",
      "  Proportionate: 1\n",
      "  chromosome: 57\n",
      "  Cortical: 1\n",
      "  Emery-Nelson: 1\n",
      "  Hepatitis: 1\n",
      "  methemoglobinemia: 2\n",
      "  congenital: 125\n",
      "  muscular: 14\n",
      "  THRA: 1\n",
      "  cleft: 22\n",
      "  neurodevelopmental: 69\n",
      "  aromatic: 1\n",
      "  Becker: 2\n",
      "  hyperuricemia,: 1\n",
      "  calcific: 1\n",
      "  Abnormal: 61\n",
      "  KLF11: 1\n",
      "  Dandy-Walker: 2\n",
      "  even-plus: 1\n",
      "  Nedocromil: 1\n",
      "  scimitar: 1\n",
      "  hawkinsinuria: 1\n",
      "  Heyn-Sproul-Jackson: 1\n",
      "  distal: 25\n",
      "  Ruvalcaba: 1\n",
      "  curved: 1\n",
      "  Tietze: 1\n",
      "  common: 1\n",
      "  diffuse: 6\n",
      "  Ehlers-Danlos: 17\n",
      "  macrothrombocytopenia-lymphedema-developmental: 1\n",
      "  Coxa: 1\n",
      "  Rifapentine: 1\n",
      "  Kleefstra: 3\n",
      "  Diamond-Blackfan: 2\n",
      "  L1: 1\n",
      "  ataxia-pancytopenia: 1\n",
      "  XIAP: 1\n",
      "  leukoencephalopathy: 5\n",
      "  3-methylcrotonyl-CoA: 3\n",
      "  glaucoma: 3\n",
      "  ermine: 1\n",
      "  short: 31\n",
      "  glycogen: 16\n",
      "  Rotor: 1\n",
      "  myopathy,: 17\n",
      "  peripheral: 5\n",
      "  gray: 1\n",
      "  cranial: 2\n",
      "  thoraco-abdominal: 1\n",
      "  Qazi: 1\n",
      "  complement: 11\n",
      "  Takotsubo: 1\n",
      "  junctional: 2\n",
      "  Verloove: 1\n",
      "  fried: 1\n",
      "  thrombocytopenia,: 1\n",
      "  IGF1: 1\n",
      "  LIPE-related: 1\n",
      "  cerebello-olivary: 1\n",
      "  dermatoleukodystrophy: 1\n",
      "  hereditary: 29\n",
      "  Multinucleated: 1\n",
      "  recessive: 4\n",
      "  RDH12: 1\n",
      "  NGFR: 1\n",
      "  cardiac: 7\n",
      "  Sanderson-Fraser: 1\n",
      "  Metatarsal: 1\n",
      "  myoclonic: 2\n",
      "  atrioventricular: 2\n",
      "  infantile: 20\n",
      "  Thoracolumbar: 1\n",
      "  Broad: 5\n",
      "  Dofetilide: 1\n",
      "  Narrow: 2\n",
      "  cardioectodermal: 1\n",
      "  Zidovudine: 1\n",
      "  episodic: 1\n",
      "  kapur-Toriello: 1\n",
      "  Wide: 3\n",
      "  Rapp-Hodgkin: 1\n",
      "  non-acquired: 1\n",
      "  retinohepatoendocrinologic: 1\n",
      "  cardiofacial: 1\n",
      "  Ketoprofen: 1\n",
      "  Hydrocortisone: 1\n",
      "  combined: 21\n",
      "  NAGLU: 1\n",
      "  developmental: 12\n",
      "  cerebellar: 12\n",
      "  SLC39A13: 1\n",
      "  Prominent: 3\n",
      "  microcephaly-facio-cardio-skeletal: 1\n",
      "  xanthinuria: 1\n",
      "  Apomorphine: 1\n",
      "  49,XXXXY: 1\n",
      "  Combarros: 1\n",
      "  tumoral: 1\n",
      "  cerebral: 10\n",
      "  ataxia: 6\n",
      "  childhood-onset: 1\n",
      "  8p11.2: 1\n",
      "  arterial: 4\n",
      "  bilateral: 6\n",
      "  Chediak-Higashi: 1\n",
      "  epidermolysis: 7\n",
      "  Frog-leg: 1\n",
      "  ASCC1: 1\n",
      "  Aplasia/Hypoplasia: 5\n",
      "  Corneal: 3\n",
      "  Popliteal: 1\n",
      "  Ramipril: 1\n",
      "  arhinia,: 1\n",
      "  neurodegeneration,: 5\n",
      "  cold: 1\n",
      "  hypomyelinating: 2\n",
      "  Diltiazem: 1\n",
      "  isobutyryl-CoA: 1\n",
      "  Increased: 5\n",
      "  Ethotoin: 1\n",
      "  beta-ketothiolase: 1\n",
      "  Joubert: 6\n",
      "  2q31.1: 1\n",
      "  MECP2: 1\n",
      "  Anomaly: 2\n",
      "  growth: 10\n",
      "  Calcitonin: 1\n",
      "  Osteoporosis: 2\n",
      "  cystic: 6\n",
      "  MEDNIK: 1\n",
      "  Unoprostone: 1\n",
      "  Wolfram: 2\n",
      "  Visceromegaly: 1\n",
      "  frontonasal: 5\n",
      "  hypohidrosis-enamel: 1\n",
      "  baetz-greenwalt: 1\n",
      "  sucrosuria,: 1\n",
      "  Sex-limited: 1\n",
      "  agyria-pachygyria: 1\n",
      "  odontoid: 1\n",
      "  hypertelorism,: 2\n",
      "  ABCC3: 1\n",
      "  syndromic: 32\n",
      "  carnitine: 7\n",
      "  CIB2: 1\n",
      "  syndesmodysplasic: 1\n",
      "  Abruzzo-Erickson: 1\n",
      "  tricarboxylic: 1\n",
      "  Dent: 1\n",
      "  Abnormally: 1\n",
      "  Irregular: 2\n",
      "  late-infantile/juvenile: 1\n",
      "  Plerixafor: 1\n",
      "  hypogonadotropic: 4\n",
      "  Depressivity: 1\n",
      "  parietal: 2\n",
      "  oculoosteocutaneous: 1\n",
      "  COG2-CDG: 1\n",
      "  Mid-frequency: 1\n",
      "  VPS54: 1\n",
      "  PDE6B: 1\n",
      "  encephalopathy,: 7\n",
      "  Desmopressin: 1\n",
      "  hypomyelination: 2\n",
      "  dyschondrosteosis-nephritis: 1\n",
      "  acromicric: 1\n",
      "  infantile-onset: 6\n",
      "  mitochondrial: 27\n",
      "  Stüve-Wiedemann: 1\n",
      "  chorea,: 3\n",
      "  acrofacial: 4\n",
      "  chronic: 12\n",
      "  levator: 1\n",
      "  Cantu: 2\n",
      "  IFNG: 1\n",
      "  multinucleated: 1\n",
      "  Brooke-Spiegler: 1\n",
      "  Mayer-Rokitansky-Küster-Hauser: 1\n",
      "  occipital: 2\n",
      "  optic: 8\n",
      "  cerebroretinal: 1\n",
      "  cataract-hypertrichosis-intellectual: 1\n",
      "  spastic: 18\n",
      "  Diflunisal: 1\n",
      "  metaphyseal: 9\n",
      "  motor: 2\n",
      "  Abnormality: 63\n",
      "  Ropivacaine: 1\n",
      "  indomethacin: 1\n",
      "  intrahepatic: 1\n",
      "  hypoplastic: 3\n",
      "  Ganirelix: 1\n",
      "  AL: 1\n",
      "  Hip: 3\n",
      "  toe,: 2\n",
      "  Tapentadol: 1\n",
      "  Fanconi: 4\n",
      "  Klippel-Feil: 3\n",
      "  severe: 36\n",
      "  Trovafloxacin: 1\n",
      "  familial: 71\n",
      "  Cortisone: 1\n",
      "  Fraser: 2\n",
      "  clubfoot: 1\n",
      "  babesiosis: 1\n",
      "  osteopathia: 2\n",
      "  Ipratropium: 1\n",
      "  8q12: 1\n",
      "  pyruvate: 9\n",
      "  Niemann-Pick: 1\n",
      "  skeletal: 10\n",
      "  ciliary: 6\n",
      "  low: 1\n",
      "  periventricular: 2\n",
      "  Splayed: 1\n",
      "  Hyperactivity: 1\n",
      "  Decreased: 6\n",
      "  Duane: 2\n",
      "  exercise: 1\n",
      "  Hennekam: 2\n",
      "  NFE2L2: 1\n",
      "  Metatarsus: 1\n",
      "  Pentosan: 1\n",
      "  Indacaterol: 1\n",
      "  Delayed: 7\n",
      "  autosomal: 71\n",
      "  transcobalamin: 2\n",
      "  RAX2: 1\n",
      "  CNS: 3\n",
      "  Laron: 1\n",
      "  hypertrophic: 4\n",
      "  spondylodysplastic: 1\n",
      "  ovarian: 4\n",
      "  rheumatoid: 3\n",
      "  postaxial: 4\n",
      "  Halothane: 1\n",
      "  Dronabinol: 1\n",
      "  20p13: 1\n",
      "  macular: 3\n",
      "  amelogenesis: 3\n",
      "  arthrogryposis: 7\n",
      "  lymph: 1\n",
      "  Budesonide: 1\n",
      "  Hutchinson-Gilford: 1\n",
      "  hypertelorism: 2\n",
      "  fallopian: 1\n",
      "  deafness-encephaloneuropathy-obesity-valvulopathy: 1\n",
      "  autoinflammation,: 1\n",
      "  MAFK: 1\n",
      "  Trospium: 1\n",
      "  oculoauriculofrontonasal: 1\n",
      "  Budd-Chiari: 1\n",
      "  high: 1\n",
      "  BD: 1\n",
      "  prostatic: 1\n",
      "  Ivory: 1\n",
      "  hypertelorism-hypospadias-polysyndactyly: 1\n",
      "  Frovatriptan: 1\n",
      "  Kallmann: 2\n",
      "  progeroid: 4\n",
      "  PLS1: 1\n",
      "  spondylocostal: 3\n",
      "  catecholaminergic: 1\n",
      "  camptodactyly-tall: 1\n",
      "  Charcot-Marie-Tooth: 5\n",
      "  Bromocriptine: 1\n",
      "  Schmitt-Gillenwater-Kelly: 1\n",
      "  leukoencephalopathy-thalamus: 1\n",
      "  heart: 5\n",
      "  PLOD1: 1\n",
      "  sclerosteosis: 1\n",
      "  Fibulo-ulnar: 1\n",
      "  PITX2: 1\n",
      "  fetal: 15\n",
      "  craniofacial: 7\n",
      "  Milner-Khallouf-Gibson: 1\n",
      "  neutrophil: 1\n",
      "  Nilotinib: 1\n",
      "  Severe: 5\n",
      "  Fluctuating: 2\n",
      "  Paganini-Miozzo: 1\n",
      "  paternal: 8\n",
      "  mosaic: 9\n",
      "  Macrocephaly: 2\n",
      "  pulmonary: 8\n",
      "  parotid: 1\n",
      "  MYO1B: 1\n",
      "  microspherophakia-metaphyseal: 1\n",
      "  craniometaphyseal: 3\n",
      "  small: 1\n",
      "  cortex: 1\n",
      "  dyskeratosis: 4\n",
      "  cataract-deafness-hypogonadism: 1\n",
      "  peho-like: 1\n",
      "  megaepiphyseal: 1\n",
      "  Mucopolysacchariduria: 1\n",
      "  beta-ureidopropionase: 1\n",
      "  microcephaly,: 11\n",
      "  Roflumilast: 1\n",
      "  mandibuloacral: 2\n",
      "  rigid: 2\n",
      "  Leukomelanoderma-infantilism-intellectual: 1\n",
      "  Quinapril: 1\n",
      "  hydrocephalus,: 2\n",
      "  isolated: 29\n",
      "  ghosal: 1\n",
      "  dysplasia: 1\n",
      "  Sorbitol: 1\n",
      "  dwarfism,: 5\n",
      "  estrogen: 1\n",
      "  proximal: 4\n",
      "  Depigmentation/hyperpigmentation: 1\n",
      "  WDR37: 1\n",
      "  Intellectual: 7\n",
      "  keratoconjunctivitis: 1\n",
      "  Amlodipine: 1\n",
      "  spondylo-ocular: 1\n",
      "  lethal: 21\n",
      "  Tyrosinosis: 1\n",
      "  arthrogryposis,: 7\n",
      "  hypogonadism,: 1\n",
      "  dystonia: 4\n",
      "  Legius: 1\n",
      "  brachyolmia,: 1\n",
      "  Nabilone: 1\n",
      "  brachydactyly-nystagmus-cerebellar: 1\n",
      "  ABCD: 1\n",
      "  CHRNA7: 1\n",
      "  Pendred: 1\n",
      "  MPS: 1\n",
      "  8p: 1\n",
      "  vitamin: 6\n",
      "  mullerian: 3\n",
      "  Beck-Fahrner: 1\n",
      "  PYCR1-related: 1\n",
      "  acquired: 4\n",
      "  cennamo: 1\n",
      "  Chlorpromazine: 1\n",
      "  osteoporosis-pseudoglioma: 1\n",
      "  Recurrent: 12\n",
      "  Supernumerary: 1\n",
      "  thymoma: 1\n",
      "  Bimatoprost: 1\n",
      "  hemoglobin: 2\n",
      "  Snoring: 1\n",
      "  thoracomelic: 1\n",
      "  Nijmegen: 2\n",
      "  craniolenticulosutural: 1\n",
      "  SIRT1: 1\n",
      "  Nelfinavir: 1\n",
      "  neonatal: 13\n",
      "  T-substance: 1\n",
      "  tibial: 4\n",
      "  intrauterine: 3\n",
      "  diaphragmatic: 5\n",
      "  conductive: 2\n",
      "  MERRF: 1\n",
      "  Citalopram: 1\n",
      "  Diazepam: 1\n",
      "  NRL: 1\n",
      "  Bloom: 1\n",
      "  spinal: 9\n",
      "  STAT3-related: 1\n",
      "  hypersomnia: 1\n",
      "  porphyria: 2\n",
      "  spondyloepimetaphyseal: 7\n",
      "  Santos: 1\n",
      "  Ramos-Arroyo: 1\n",
      "  Normal: 1\n",
      "  Brimonidine: 1\n",
      "  Toriello-Carey: 1\n",
      "  acropectorovertebral: 1\n",
      "  thyroid: 6\n",
      "  atypical: 9\n",
      "  drug: 1\n",
      "  INTS1: 1\n",
      "  Ranolazine: 1\n",
      "  faciocardiorenal: 1\n",
      "  Stavudine: 1\n",
      "  Cytarabine: 1\n",
      "  X: 1\n",
      "  constitutional: 1\n",
      "  hypophosphatemic: 3\n",
      "  CASP3: 1\n",
      "  Werner: 1\n",
      "  Imiquimod: 1\n",
      "  ataxia-photosensitivity-short: 1\n",
      "  Lamb-Shaffer: 1\n",
      "  Reviparin: 1\n",
      "  Carboplatin: 1\n",
      "  Propofol: 1\n",
      "  goniodysgenesis: 1\n",
      "  hyperuricemia-pulmonary: 1\n",
      "  PEHO: 1\n",
      "  female: 2\n",
      "  48,XXXY: 1\n",
      "  Cranial: 1\n",
      "  Charlevoix-Saguenay: 1\n",
      "  Osteoarthritis: 1\n",
      "  Oliver: 1\n",
      "  platelet-type: 1\n",
      "  chorea-acanthocytosis: 1\n",
      "  Edinburgh: 1\n",
      "  Goodman: 1\n",
      "  nephrosis-deafness-urinary: 1\n",
      "  Dabigatran: 1\n",
      "  XFE: 1\n",
      "  neurofaciodigitorenal: 1\n",
      "  pili: 2\n",
      "  Treacher-Collins: 2\n",
      "  Babinski: 1\n",
      "  Blindness: 1\n",
      "  TRIOBP: 1\n",
      "  cataract: 6\n",
      "  thoracic: 5\n",
      "  Mexiletine: 1\n",
      "  craniotelencephalic: 1\n",
      "  Tourette: 1\n",
      "  Gemcitabine: 1\n",
      "  CHAND: 1\n",
      "  deafness-epiphyseal: 1\n",
      "  aphalangy-syndactyly-microcephaly: 1\n",
      "  Hearing: 2\n",
      "  Dopamine: 1\n",
      "  progressive: 19\n",
      "  Roifman: 1\n",
      "  hypotonia: 1\n",
      "  upper: 1\n",
      "  pituitary: 7\n",
      "  CHD7: 1\n",
      "  Wolfram-like: 1\n",
      "  hair: 2\n",
      "  craniosynostosis,: 1\n",
      "  pachydermodactyly,: 1\n",
      "  alpha: 4\n",
      "  Gadoteridol: 1\n",
      "  Noncommunicating: 1\n",
      "  Schmid: 1\n",
      "  Human: 1\n",
      "  CRX: 1\n",
      "  Xq27.3q28: 1\n",
      "  Canavan: 1\n",
      "  Stickler: 1\n",
      "  Arnold: 1\n",
      "  Galloway-Mowat: 2\n",
      "  neuronal: 3\n",
      "  Freesia: 1\n",
      "  visual: 1\n",
      "  Octreotide: 1\n",
      "  basal: 3\n",
      "  Timothy: 1\n",
      "  plasma: 2\n",
      "  AHR: 1\n",
      "  kaposiform: 1\n",
      "  Darifenacin: 1\n",
      "  Cerivastatin: 1\n",
      "  CHST14: 1\n",
      "  RHO: 1\n",
      "  3-methylglutaconic: 3\n",
      "  3-hydroxyacyl-CoA: 1\n",
      "  diphallus: 1\n",
      "  heart-hand: 1\n",
      "  Conductive: 1\n",
      "  abetalipoproteinemia: 1\n",
      "  PSEN1: 1\n",
      "  Hallermann-Streiff: 1\n",
      "  Lassa: 1\n",
      "  Mode: 1\n",
      "  Arthritis: 1\n",
      "  sacral: 1\n",
      "  neutropenia,: 2\n",
      "  thrombocytopenia-absent: 1\n",
      "  myopathy: 5\n",
      "  Amiloride: 1\n",
      "  ectopic: 1\n",
      "  Alport: 1\n",
      "  Martinez-Frias: 1\n",
      "  Compton-North: 1\n",
      "  coronary: 2\n",
      "  hypermanganesemia: 1\n",
      "  Nager: 1\n",
      "  Monosomy: 1\n",
      "  hydrops: 1\n",
      "  46,XY: 5\n",
      "  Kozlowski: 3\n",
      "  Bothnia: 1\n",
      "  Mandibular: 1\n",
      "  penile/testicular: 1\n",
      "  body: 1\n",
      "  biliary: 3\n",
      "  Plummer-Vinson: 1\n",
      "  laryngeal: 3\n",
      "  EIF2S1: 1\n",
      "  atresia: 1\n",
      "  sudden: 3\n",
      "  Fukuda-Miyanomae-Nakata: 1\n",
      "  Dobutamine: 1\n",
      "  Pointed: 1\n",
      "  autism: 3\n",
      "  celiac: 1\n",
      "  cutis: 10\n",
      "  renal: 11\n",
      "  Retinopathy: 2\n",
      "  Depressed: 1\n",
      "  Capgras: 1\n",
      "  Richieri: 2\n",
      "  Adenoiditis: 1\n",
      "  lissencephaly: 8\n",
      "  Vagneur-Triolle-Ripert: 1\n",
      "  glycoprotein: 1\n",
      "  cysteine: 1\n",
      "  acromesomelic: 2\n",
      "  Heparan: 1\n",
      "  cerebrotendinous: 1\n",
      "  karyomegalic: 1\n",
      "  NOTCH1: 1\n",
      "  atrial: 4\n",
      "  Caspofungin: 1\n",
      "  Alagille: 2\n",
      "  Cri-du-chat: 1\n",
      "  Aripiprazole: 1\n",
      "  preimplantation: 1\n",
      "  Mirtazapine: 1\n",
      "  Synostosis: 1\n",
      "  non-distal: 4\n",
      "  auriculoosteodysplasia: 1\n",
      "  TNF: 1\n",
      "  Sotos: 1\n",
      "  MEGF8-related: 1\n",
      "  Spondyloepiphyseal: 1\n",
      "  Ifosfamide: 1\n",
      "  PLAT: 1\n",
      "  Pravastatin: 1\n",
      "  MPZ: 1\n",
      "  Elbow: 2\n",
      "  multiple: 24\n",
      "  pyropoikilocytosis,: 1\n",
      "  febrile: 1\n",
      "  craniosynostosis-anal: 1\n",
      "  Rosselli-Gulienetti: 1\n",
      "  hypotonia,: 4\n",
      "  Protuberant: 1\n",
      "  contractures-developmental: 1\n",
      "  polysyndactyly: 1\n",
      "  aorto-ventricular: 1\n",
      "  Liothyronine: 1\n",
      "  epilepsy,: 6\n",
      "  interstitial: 1\n",
      "  taurodontism,: 1\n",
      "  Valproic: 1\n",
      "  microcephaly-capillary: 1\n",
      "  autoimmune: 10\n",
      "  Malabsorption: 1\n",
      "  Nitisinone: 1\n",
      "  Limited: 5\n",
      "  PRSS35: 1\n",
      "  Growth: 2\n",
      "  blepharonasofacial: 1\n",
      "  mesomelia-synostoses: 1\n",
      "  SELENOP: 1\n",
      "  osteosclerosis-developmental: 1\n",
      "  Zechi-Ceide: 1\n",
      "  Angelman: 4\n",
      "  TJP2: 1\n",
      "  Stiff: 10\n",
      "  Mephenytoin: 1\n",
      "  hepatorenal: 1\n",
      "  deafness-enamel: 1\n",
      "  Minocycline: 1\n",
      "  hemimegalencephaly: 1\n",
      "  burn: 1\n",
      "  hypouricemia,: 2\n",
      "  Motor: 1\n",
      "  8q22.1: 1\n",
      "  transgrediens: 1\n",
      "  GNE: 1\n",
      "  PSAT: 1\n",
      "  AMMECR1: 1\n",
      "  Carbamoylcholine: 1\n",
      "  Temple-Baraitser: 1\n",
      "  generalized: 3\n",
      "  Opitz: 1\n",
      "  medium: 2\n",
      "  Leigh: 4\n",
      "  Triptorelin: 1\n",
      "  polysaccharide,: 1\n",
      "  cryptorchidism-arachnodactyly-intellectual: 1\n",
      "  desmosterolosis: 1\n",
      "  Pigmentary: 1\n",
      "  Moyamoya: 2\n",
      "  hilar: 1\n",
      "  Vitiligo: 1\n",
      "  Caffey: 1\n",
      "  anophthalmia: 3\n",
      "  macrogyria,: 1\n",
      "  coenzyme: 1\n",
      "  stomach: 1\n",
      "  PDGFB: 1\n",
      "  contractures,: 2\n",
      "  aminopterin/methotrexate: 1\n",
      "  double: 4\n",
      "  triploidy: 1\n",
      "  Wolcott-Rallison: 1\n",
      "  Down: 1\n",
      "  frontometaphyseal: 1\n",
      "  ALG8-CDG: 1\n",
      "  Verteporfin: 1\n",
      "  SHORT: 1\n",
      "  Fatigable: 1\n",
      "  trichoodontoonychial: 1\n",
      "  Quetiapine: 1\n",
      "  functioning: 1\n",
      "  Joint: 5\n",
      "  brucellosis: 1\n",
      "  Riley-Day: 1\n",
      "  oculorenocerebellar: 1\n",
      "  osteochondrodysplasia,: 2\n",
      "  Mental: 1\n",
      "  Temporomandibular: 1\n",
      "  porencephaly-microcephaly-bilateral: 1\n",
      "  tricho-retino-dento-digital: 1\n",
      "  J-shaped: 1\n",
      "  Vincristine: 1\n",
      "  temtamy: 2\n",
      "  mega-corpus-callosum: 1\n",
      "  camptodactyly-taurinuria: 1\n",
      "  Kienbock: 1\n",
      "  limb: 2\n",
      "  deoxyribose-5-phosphate: 1\n",
      "  Gait: 1\n",
      "  Respiratory: 2\n",
      "  cleidocranial: 2\n",
      "  Townes-Brocks: 1\n",
      "  TMEM165-CDG: 1\n",
      "  nonprogressive: 1\n",
      "  Crouzon: 2\n",
      "  Flecainide: 1\n",
      "  nondisjunction: 1\n",
      "  deafness-genital: 1\n",
      "  late-onset: 3\n",
      "  prolactin: 2\n",
      "  Hemimacroglossia: 1\n",
      "  gapo: 1\n",
      "  CACNA2D2: 1\n",
      "  Bifid: 2\n",
      "  Simpson-Golabi-Behmel: 1\n",
      "  Terbinafine: 1\n",
      "  Lennox-Gastaut: 1\n",
      "  Pygmy: 1\n",
      "  Tafluprost: 1\n",
      "  Kuster: 2\n",
      "  Bamforth-Lazarus: 1\n",
      "  Gingival: 1\n",
      "  Prochlorperazine: 1\n",
      "  maternally-inherited: 4\n",
      "  Valdecoxib: 1\n",
      "  Tay-Sachs: 2\n",
      "  CTNNB1: 1\n",
      "  Fluoxymesterone: 1\n",
      "  atransferrinemia: 1\n",
      "  iniencephaly: 1\n",
      "  Tukel: 1\n",
      "  Ho-Kaufman-McAlister: 1\n",
      "  corpus: 8\n",
      "  AIDS: 1\n",
      "  Oxycodone: 1\n",
      "  Marinesco-Sjogren-like: 1\n",
      "  orofaciodigital: 1\n",
      "  Pelger-Huet-like: 1\n",
      "  susceptibility: 3\n",
      "  Tetracosactide: 1\n",
      "  oromandibular: 1\n",
      "  Aagenaes: 1\n",
      "  Shortened: 1\n",
      "  senile: 1\n",
      "  Furosemide: 1\n",
      "  TCR-alpha-beta-positive: 1\n",
      "  pontine: 1\n",
      "  tongue,: 1\n",
      "  lysosomal: 8\n",
      "  Eagle: 1\n",
      "  Fluoxetine: 1\n",
      "  Finnish: 2\n",
      "  deafness,: 9\n",
      "  Halcinonide: 1\n",
      "  capillary: 2\n",
      "  branchio-oto-renal: 1\n",
      "  lipoid: 1\n",
      "  Imagawa-Matsumoto: 1\n",
      "  TCF12-related: 1\n",
      "  RNASEH2B: 1\n",
      "  ZNF292: 1\n",
      "  corticobasal: 1\n",
      "  Wiedemann-Rautenstrauch: 1\n",
      "  Emanuel: 1\n",
      "  Carney-Stratakis: 1\n",
      "  oculo-auriculo-vertebral: 1\n",
      "  Coenzyme: 1\n",
      "  spondylometaphyseal: 4\n",
      "  Naratriptan: 1\n",
      "  Macular: 1\n",
      "  maternal: 11\n",
      "  SMARCD1: 1\n",
      "  Peripheral: 4\n",
      "  acute: 12\n",
      "  RHYNS: 1\n",
      "  taurodontia-absent: 1\n",
      "  Fractured: 6\n",
      "  Vardenafil: 1\n",
      "  acatalasia: 1\n",
      "  orotic: 1\n",
      "  galactosemia: 1\n",
      "  alopecia: 7\n",
      "  macrosomia-microphthalmia-cleft: 1\n",
      "  immune: 2\n",
      "  aplasia: 2\n",
      "  Cernunnos-XLF: 1\n",
      "  Abacavir: 1\n",
      "  FANCG: 1\n",
      "  chondrodysplasia: 6\n",
      "  SMPX: 1\n",
      "  insulin-resistance: 1\n",
      "  lymphoid: 2\n",
      "  craniosynostosis: 4\n",
      "  amino: 1\n",
      "  giant: 1\n",
      "  pontocerebellar: 2\n",
      "  Glycopyrronium: 1\n",
      "  myofibromatosis: 1\n",
      "  dopa-responsive: 2\n",
      "  Lethal: 1\n",
      "  SH3PXD2B: 1\n",
      "  agnathia-otocephaly: 1\n",
      "  microphthalmia: 7\n",
      "  factor: 6\n",
      "  Moderate: 2\n",
      "  pyridoxine-dependent: 2\n",
      "  Vinblastine: 1\n",
      "  nephronophthisis: 1\n",
      "  carpal: 2\n",
      "  polymicrogyria: 3\n",
      "  desmoplastic: 1\n",
      "  bruyn: 1\n",
      "  Ioxilan: 1\n",
      "  polymicrogyria,: 2\n",
      "  Calvarial: 1\n",
      "  esophageal: 2\n",
      "  ESRRB: 1\n",
      "  PISD: 1\n",
      "  recurrent: 3\n",
      "  Brody: 1\n",
      "  disease: 3\n",
      "  epsilon-trimethyllysine: 1\n",
      "  Mometasone: 1\n",
      "  Jalili: 1\n",
      "  dysmorphism-cleft: 1\n",
      "  juvenile: 12\n",
      "  Aggressive: 1\n",
      "  Mobius: 1\n",
      "  LAMB2-related: 1\n",
      "  primary: 18\n",
      "  Bannayan-Riley-Ruvalcaba: 1\n",
      "  sensory: 1\n",
      "  Waterhouse-Friderichsen: 1\n",
      "  sensorineural: 1\n",
      "  Etravirine: 1\n",
      "  Smith-Lemli-Opitz: 1\n",
      "  Hunter-McAlpine: 1\n",
      "  Jaffer-Beighton: 1\n",
      "  GLB1: 1\n",
      "  Feingold: 2\n",
      "  T-B+: 4\n",
      "  Lateral: 1\n",
      "  FANCA: 1\n",
      "  Smith-McCort: 1\n",
      "  Chondroitin: 2\n",
      "  obstructive: 1\n",
      "  methionine: 2\n",
      "  cervical: 3\n",
      "  branchial: 1\n",
      "  3p-: 1\n",
      "  encephalopathy: 6\n",
      "  colonic: 2\n",
      "  tracheobronchopathia: 1\n",
      "  Shukla-Vernon: 1\n",
      "  encephalocraniocutaneous: 1\n",
      "  pseudodiastrophic: 1\n",
      "  XYLT1-CDG: 1\n",
      "  cyanosis,: 1\n",
      "  Anagrelide: 1\n",
      "  Perphenazine: 1\n",
      "  Talipes: 1\n",
      "  teratoma,: 1\n",
      "  Karsch-Neugebauer: 1\n",
      "  Marshall-Smith: 1\n",
      "  cardioauditory: 1\n",
      "  cataract-intellectual: 2\n",
      "  classic: 4\n",
      "  coloboma: 2\n",
      "  XK: 1\n",
      "  Multiple: 4\n",
      "  DICER1: 1\n",
      "  Fosphenytoin: 1\n",
      "  10q22.3q23.3: 1\n",
      "  cholesteryl: 1\n",
      "  Enlarged: 3\n",
      "  pachyonychia: 1\n",
      "  holoprosencephaly: 3\n",
      "  Romiplostim: 1\n",
      "  brain: 5\n",
      "  Absent: 3\n",
      "  thymic: 1\n",
      "  antithrombin: 1\n",
      "  myotonia: 2\n",
      "  major: 1\n",
      "  systemic-onset: 1\n",
      "  spondyloepiphyseal: 8\n",
      "  nanophthalmos: 1\n",
      "  Trandolapril: 1\n",
      "  focal: 8\n",
      "  Pseudoephedrine: 1\n",
      "  silver-Russell: 5\n",
      "  dihydropyrimidinuria: 1\n",
      "  ossification: 2\n",
      "  piebaldism: 1\n",
      "  Nabumetone: 1\n",
      "  choanal: 2\n",
      "  central: 6\n",
      "  global: 8\n",
      "  cryptomicrotia-brachydactyly-excess: 1\n",
      "  Li-Ghorbani-Weisz-Hubshman: 1\n",
      "  mesomelic: 3\n",
      "  cerebrooculofacioskeletal: 1\n",
      "  proteinuria,: 2\n",
      "  Pimecrolimus: 1\n",
      "  Achenbach: 1\n",
      "  Gaucher: 4\n",
      "  cloverleaf: 1\n",
      "  Gadoversetamide: 1\n",
      "  Punctate: 2\n",
      "  SchC6pf-Schulz-Passarge: 1\n",
      "  Doxycycline: 1\n",
      "  Froelich: 1\n",
      "  PGM3-CDG: 1\n",
      "  TBCK-related: 1\n",
      "  harderoporphyria: 1\n",
      "  dysspondyloenchondromatosis: 1\n",
      "  micromelic: 1\n",
      "  encephalocele: 2\n",
      "  Cervical: 4\n",
      "  trypsinogen: 1\n",
      "  Zopiclone: 1\n",
      "  THOC6-related: 1\n",
      "  bullous: 1\n",
      "  Clavicular: 1\n",
      "  Marchiafava-Bignami: 1\n",
      "  dextrocardia: 3\n",
      "  ectodermal: 12\n",
      "  tonsil: 1\n",
      "  delta-1-pyrroline-5-carboxylate: 1\n",
      "  Cefditoren: 1\n",
      "  Stankiewicz-Isidor: 1\n",
      "  Dactinomycin: 1\n",
      "  Smith-Magenis: 1\n",
      "  Apnea: 1\n",
      "  toxic: 2\n",
      "  GRXCR1: 1\n",
      "  Tube: 1\n",
      "  inborn: 3\n",
      "  nephrolithiasis: 1\n",
      "  citrulline: 1\n",
      "  Appendicular: 1\n",
      "  Hartsfield-Bixler-Demyer: 1\n",
      "  cephalin: 1\n",
      "  Parinaud: 1\n",
      "  Greenberg: 1\n",
      "  Perlman: 1\n",
      "  Quinidine: 1\n",
      "  Daunorubicin: 1\n",
      "  Senior-Loken: 1\n",
      "  microcephalic: 6\n",
      "  Labetalol: 1\n",
      "  fibrosis,: 1\n",
      "  squalene: 1\n",
      "  methylmalonic: 5\n",
      "  dysostosis,: 1\n",
      "  Selegiline: 1\n",
      "  choreoathetosis,: 1\n",
      "  polyvalvular: 1\n",
      "  Verapamil: 1\n",
      "  Duchenne: 2\n",
      "  21q22.11q22.12: 1\n",
      "  Toriello-Lacassie-Droste: 1\n",
      "  Eclabion: 1\n",
      "  LRRK2: 1\n",
      "  non-syndromic: 1\n",
      "  scapula,: 1\n",
      "  Lesch-Nyhan: 2\n",
      "  Neurodevelopmental: 2\n",
      "  nocardiosis: 1\n",
      "  Deferoxamine: 1\n",
      "  chorioretinopathy: 1\n",
      "  hyperammonemia: 1\n",
      "  Proteus: 1\n",
      "  CINCA: 1\n",
      "  Ventriculomegaly: 1\n",
      "  Proteus-like: 1\n",
      "  neuropathy,: 5\n",
      "  opsismodysplasia: 1\n",
      "  osteosclerotic: 1\n",
      "  secretory: 1\n",
      "  Mikati-Najjar-Sahli: 1\n",
      "  thyrocerebrorenal: 1\n",
      "  C1QTNF5: 1\n",
      "  mantle: 1\n",
      "  Ciprofloxacin: 1\n",
      "  Salbutamol: 1\n",
      "  lung: 4\n",
      "  hypopituitarism: 1\n",
      "  Pilocarpine: 1\n",
      "  Chloroquine: 1\n",
      "  mastocytosis: 1\n",
      "  woolly: 3\n",
      "  Clonazepam: 1\n",
      "  tolosa-Hunt: 1\n",
      "  TECTA: 1\n",
      "  microphthalmia,: 1\n",
      "  dihydropyrimidine: 1\n",
      "  HS-GAG: 1\n",
      "  hypogonadism: 1\n",
      "  Fluvoxamine: 1\n",
      "  Tobramycin: 1\n",
      "  COG7-CDG: 1\n",
      "  varicella,: 1\n",
      "  Miller-Dieker: 1\n",
      "  Rett: 2\n",
      "  amyloidosis,: 1\n",
      "  RNR1: 1\n",
      "  Barth: 1\n",
      "  pachygyria-intellectual: 1\n",
      "  dentatorubral-pallidoluysian: 1\n",
      "  Hutterite: 1\n",
      "  parkinsonism: 2\n",
      "  Hurler-Scheie: 1\n",
      "  dry: 1\n",
      "  Telmisartan: 1\n",
      "  CNTF: 1\n",
      "  African: 1\n",
      "  hyperparathyroidism,: 2\n",
      "  Stargardt: 1\n",
      "  Stormorken: 1\n",
      "  patent: 1\n",
      "  Olmesartan: 1\n",
      "  PSPH: 1\n",
      "  Impaired: 1\n",
      "  von: 3\n",
      "  Craniofacial: 1\n",
      "  LMCD1: 1\n",
      "  Eng-Strom: 1\n",
      "  GIPC3: 1\n",
      "  ARG2: 1\n",
      "  Failure: 1\n",
      "  popliteal: 1\n",
      "  GMS: 1\n",
      "  Mesalazine: 1\n",
      "  Efavirenz: 1\n",
      "  MECOM: 1\n",
      "  dystonia-aphonia: 1\n",
      "  olivopontocerebellar: 2\n",
      "  visceral: 3\n",
      "  Anterior: 5\n",
      "  hyperuricemic: 1\n",
      "  hypoprebetalipoproteinemia,: 1\n",
      "  alpha-2-plasmin: 1\n",
      "  ZMIZ1: 1\n",
      "  porencephaly-cerebellar: 1\n",
      "  synaptic: 1\n",
      "  Kasznica-Carlson-Coppedge: 1\n",
      "  Tangier: 1\n",
      "  Pigmentation: 1\n",
      "  MEND: 1\n",
      "  megalocornea-intellectual: 1\n",
      "  mycosis: 1\n",
      "  Hoyeraal-Hreidarsson: 1\n",
      "  Iopamidol: 1\n",
      "  Ghose-Sachdev-Kumar: 1\n",
      "  immunodeficiency-centromeric: 1\n",
      "  angioosteohypertrophic: 1\n",
      "  autoinflammation: 2\n",
      "  Borrone: 1\n",
      "  pycnodysostosis: 1\n",
      "  Carmustine: 1\n",
      "  Mild: 3\n",
      "  anterior: 3\n",
      "  MAPK14: 1\n",
      "  Beemer-Langer: 1\n",
      "  Nyctalopia: 1\n",
      "  Hurler: 1\n",
      "  deafness-intellectual: 1\n",
      "  TSC2: 1\n",
      "  turnpenny-fry: 1\n",
      "  Birth: 1\n",
      "  splenomegaly: 1\n",
      "  acrorenal: 1\n",
      "  schizencephaly: 1\n",
      "  heparin: 1\n",
      "  saliva-secreting: 1\n",
      "  deafness: 8\n",
      "  Bruck: 1\n",
      "  Dipyridamole: 1\n",
      "  median: 1\n",
      "  gamma-A-globulin,: 1\n",
      "  DK1-CDG: 1\n",
      "  TMIE: 1\n",
      "  frontotemporal: 2\n",
      "  Turner: 2\n",
      "  foix: 1\n",
      "  camptodactyly-arthropathy-coxa: 1\n",
      "  CDC14A: 1\n",
      "  XY: 1\n",
      "  Progressive: 9\n",
      "  Idarubicin: 1\n",
      "  osteomalacia,: 1\n",
      "  NRAS: 1\n",
      "  Rubinstein-Taybi: 4\n",
      "  Richards-Rundle: 1\n",
      "  hypochondroplasia: 1\n",
      "  Brachymorphism-onychodysplasia-dysphalangism: 1\n",
      "  Atrial: 1\n",
      "  adiposis: 1\n",
      "  Dyggve-Melchior-Clausen: 2\n",
      "  APP: 1\n",
      "  Topiramate: 1\n",
      "  partial: 3\n",
      "  hyper-IgM: 1\n",
      "  Thoracic: 1\n",
      "  SOD2: 1\n",
      "  Jawad: 1\n",
      "  prominent: 1\n",
      "  Mupirocin: 1\n",
      "  maleylacetoacetate: 1\n",
      "  Schrander-stumpel-Theunissen-Hulsmans: 1\n",
      "  cystinosis: 1\n",
      "  succinyl-CoA:3-ketoacid: 1\n",
      "  benign: 5\n",
      "  glutaric: 1\n",
      "  APOE: 1\n",
      "  Genital: 1\n",
      "  Glycine: 1\n",
      "  Isosorbide: 2\n",
      "  EYA1: 1\n",
      "  oculocerebral: 2\n",
      "  absence: 3\n",
      "  de: 3\n",
      "  Warfarin: 1\n",
      "  Clozapine: 1\n",
      "  RDX: 1\n",
      "  macrocephaly,: 4\n",
      "  manganese: 1\n",
      "  Baraitser-winter: 1\n",
      "  Frias: 1\n",
      "  peroxisomal: 1\n",
      "  absent: 4\n",
      "  mast: 2\n",
      "  Skraban-Deardorff: 1\n",
      "  acheiropody: 1\n",
      "  Milnacipran: 1\n",
      "  nevoid: 1\n",
      "  Gilbert: 1\n",
      "  cardio-renal: 1\n",
      "  Cevimeline: 1\n",
      "  diaminopentanuria: 1\n",
      "  thanatophoric: 2\n",
      "  Bohring-Opitz: 1\n",
      "  Sagliker: 1\n",
      "  thromboangiitis: 1\n",
      "  bronchopulmonary: 1\n",
      "  microspherophakia: 1\n",
      "  Omenn: 1\n",
      "  Waldenstrom: 1\n",
      "  Doxepin: 1\n",
      "  Darier: 1\n",
      "  cartilage-hair: 1\n",
      "  beta: 1\n",
      "  Gerstmann-Straussler-Scheinker: 1\n",
      "  Parasomnia: 1\n",
      "  polycystic: 6\n",
      "  Pyrazinamide: 1\n",
      "  Clomipramine: 1\n",
      "  trichothiodystrophy: 3\n",
      "  KCNJ4: 1\n",
      "  Thick: 6\n",
      "  PAGOD: 1\n",
      "  Tadalafil: 1\n",
      "  Mietens: 1\n",
      "  brachydactyly-elbow: 1\n",
      "  NKX2-1: 1\n",
      "  facioscapulohumeral: 1\n",
      "  tricho-hepato-enteric: 1\n",
      "  fibrochondrogenesis: 1\n",
      "  Cidofovir: 1\n",
      "  Thickened: 2\n",
      "  GM3: 1\n",
      "  amelocerebrohypohidrotic: 1\n",
      "  Nicotine: 1\n",
      "  Emedastine: 1\n",
      "  UGP2: 1\n",
      "  retinitis: 7\n",
      "  myasthenic: 4\n",
      "  thrombophilia: 2\n",
      "  myxedema: 1\n",
      "  Bowing: 1\n",
      "  Sjogren-Larsson: 1\n",
      "  PAX7: 1\n",
      "  Autosomal: 2\n",
      "  Hirsutism: 1\n",
      "  kyphoscoliosis-lateral: 1\n",
      "  Czech: 1\n",
      "  Bivalirudin: 1\n",
      "  Avascular: 2\n",
      "  CHILD: 1\n",
      "  microcephaly-micromelia: 1\n",
      "  hypohidrotic: 2\n",
      "  alopecia-intellectual: 2\n",
      "  tibia,: 1\n",
      "  cranio-osteoarthropathy: 1\n",
      "  Interferon: 1\n",
      "  Prieto: 1\n",
      "  carcinoid: 1\n",
      "  ophthalmoplegia,: 2\n",
      "  Pamidronic: 1\n",
      "  GJB3: 1\n",
      "  propionic: 1\n",
      "  epileptic: 1\n",
      "  CYP1A1: 1\n",
      "  glucocorticoid: 2\n",
      "  ADAM3A: 1\n",
      "  CCL2: 1\n",
      "  craniofaciofrontodigital: 1\n",
      "  Apraclonidine: 1\n",
      "  Raynaud: 1\n",
      "  acrofrontofacionasal: 1\n",
      "  facial: 12\n",
      "  lymphopenic: 1\n",
      "  Christian: 2\n",
      "  15q: 1\n",
      "  Cone-shaped: 1\n",
      "  autoinflammatory: 1\n",
      "  P4HTM: 1\n",
      "  dermatomyositis: 1\n",
      "  complex: 5\n",
      "  VACTERL: 2\n",
      "  faciothoracogenital: 1\n",
      "  nephrogenic: 2\n",
      "  Robinow: 1\n",
      "  Eiken: 1\n",
      "  ABHD12: 1\n",
      "  NPHP3-related: 1\n",
      "  trigonocephaly-short: 1\n",
      "  osteoporosis-macrocephaly-blindness-joint: 1\n",
      "  OTX2: 1\n",
      "  alpha-heavy: 1\n",
      "  Schlegelberger-Grote: 1\n",
      "  Nalidixic: 1\n",
      "  xeroderma: 2\n",
      "  metabolic: 5\n",
      "  Cerebral: 1\n",
      "  beta-mannosidosis: 1\n",
      "  agnathia-microstomia-synotia: 1\n",
      "  dehydrated: 1\n",
      "  fumaric: 1\n",
      "  cutaneous: 3\n",
      "  SBSPON: 1\n",
      "  plague: 1\n",
      "  SLC10A7: 1\n",
      "  palant: 1\n",
      "  Roberts: 1\n",
      "  Tranexamic: 1\n",
      "  blue: 2\n",
      "  larynx: 1\n",
      "  RNF13: 1\n",
      "  prefrontal: 1\n",
      "  Torasemide: 1\n",
      "  deafness-lymphedema-leukemia: 1\n",
      "  Langer: 1\n",
      "  Norrie: 1\n",
      "  cystathioninuria: 1\n",
      "  gastric: 2\n",
      "  psoriatic: 1\n",
      "  Angina: 1\n",
      "  Fluorescein: 1\n",
      "  autism-facial: 1\n",
      "  Chitayat: 1\n",
      "  renal-genital-middle: 1\n",
      "  otoonychoperoneal: 1\n",
      "  diabetic: 2\n",
      "  FGFR2-related: 1\n",
      "  ALG2-CDG: 1\n",
      "  Lymphedema: 1\n",
      "  endocardial: 2\n",
      "  Zolmitriptan: 1\n",
      "  BENTA: 1\n",
      "  lymphedema,: 1\n",
      "  Paris-Trousseau: 1\n",
      "  Lelis: 1\n",
      "  delayed: 2\n",
      "  hypogonadism-mitral: 1\n",
      "  knuckle: 1\n",
      "  Urofollitropin: 1\n",
      "  pineoblastoma: 1\n",
      "  Symmetric: 1\n",
      "  hemophagocytic: 2\n",
      "  CAMOS: 1\n",
      "  Guanfacine: 1\n",
      "  thrombotic: 1\n",
      "  retinal: 11\n",
      "  Zanamivir: 1\n",
      "  kyphomelic: 1\n",
      "  fibrodysplasia: 1\n",
      "  hypercoagulability: 1\n",
      "  Reye: 1\n",
      "  engelhard: 1\n",
      "  atrichia: 1\n",
      "  mendelian: 3\n",
      "  PURA-related: 2\n",
      "  microcephaly-intellectual: 2\n",
      "  subacute: 1\n",
      "  pilodental: 1\n",
      "  vertebral: 2\n",
      "  CEBALID: 1\n",
      "  hyaline: 1\n",
      "  MIR96: 1\n",
      "  Everolimus: 1\n",
      "  Platyspondyly: 1\n",
      "  cranioectodermal: 1\n",
      "  spondylocamptodactyly: 1\n",
      "  anophthalmia-megalocornea-cardiopathy-skeletal: 1\n",
      "  Enfuvirtide: 1\n",
      "  childhood: 5\n",
      "  sodium-potassium-ATPase: 1\n",
      "  drachtman: 1\n",
      "  hemolytic: 7\n",
      "  L-Glutamine: 1\n",
      "  tetrasomy: 1\n",
      "  Fenoldopam: 1\n",
      "  Bartsocas-Papas: 1\n",
      "  velocardiofacial: 1\n",
      "  CYP1A2: 1\n",
      "  asymmetric: 1\n",
      "  acrocapitofemoral: 1\n",
      "  Liang-Wang: 1\n",
      "  Lambotte: 1\n",
      "  Hyperorality: 1\n",
      "  Muromonab: 1\n",
      "  Metformin: 1\n",
      "  TPRN: 1\n",
      "  hydrolethalus: 1\n",
      "  GRIN2D: 1\n",
      "  fallot: 1\n",
      "  ATRN: 1\n",
      "  arachnoiditis: 1\n",
      "  Haim-Munk: 1\n",
      "  chylomicronemia,: 1\n",
      "  Lisinopril: 1\n",
      "  Doxercalciferol: 1\n",
      "  IRIDA: 1\n",
      "  diverticulosis,: 1\n",
      "  Chenodeoxycholic: 1\n",
      "  kidney: 1\n",
      "  metachromatic: 2\n",
      "  fundus: 3\n",
      "  prune: 2\n",
      "  Larsen: 1\n",
      "  camptodactyly: 5\n",
      "  diastrophic: 1\n",
      "  Bupropion: 1\n",
      "  eccentrochondrodysplasia: 1\n",
      "  CK: 1\n",
      "  indolylacroyl: 1\n",
      "  ALG11-CDG: 1\n",
      "  ARSB: 1\n",
      "  Levonorgestrel: 1\n",
      "  Kniest-like: 1\n",
      "  amaurosis-hypertrichosis: 1\n",
      "  very: 1\n",
      "  Telbivudine: 1\n",
      "  zebra: 1\n",
      "  odonto-tricho-ungual-digito-palmar: 1\n",
      "  Valaciclovir: 1\n",
      "  superior: 3\n",
      "  Trabectedin: 1\n",
      "  Aicardi: 1\n",
      "  Etoricoxib: 1\n",
      "  Horizontal: 1\n",
      "  Paraparesis: 1\n",
      "  six2-related: 1\n",
      "  hypoplasminogenemia: 1\n",
      "  adrenal: 4\n",
      "  13q12.3: 1\n",
      "  Ethosuximide: 1\n",
      "  branchiogenic: 1\n",
      "  keratitis: 1\n",
      "  MEGF10-Related: 1\n",
      "  podder-tolmie: 1\n",
      "  COG8-CDG: 1\n",
      "  Temsirolimus: 1\n",
      "  LEPR: 1\n",
      "  Carney: 2\n",
      "  TWIST1-related: 1\n",
      "  omphalocele: 1\n",
      "  Atkin-Flaitz: 1\n",
      "  Metaphyseal: 3\n",
      "  hypereosinophilic: 1\n",
      "  MASA: 1\n",
      "  Donepezil: 1\n",
      "  Freckling: 1\n",
      "  leishmaniasis,: 1\n",
      "  Thiotepa: 1\n",
      "  marfanoid: 4\n",
      "  mandibular: 1\n",
      "  Microdontia: 2\n",
      "  Bretylium: 1\n",
      "  Nelarabine: 1\n",
      "  Marinesco-Sjogren: 1\n",
      "  Widely: 1\n",
      "  short-limb: 1\n",
      "  glycine: 2\n",
      "  Tiotropium: 1\n",
      "  skin: 2\n",
      "  Legg-Calve-Perthes: 1\n",
      "  B4GALT1-CDG: 1\n",
      "  brachydactyly,: 4\n",
      "  HGSNAT: 1\n",
      "  Jumping: 1\n",
      "  NOS2: 1\n",
      "  tendon: 1\n",
      "  Splenomegaly: 1\n",
      "  histidinuria: 1\n",
      "  palmaris: 1\n",
      "  Constrictive: 1\n",
      "  dihydropteridine: 1\n",
      "  fibular: 3\n",
      "  van: 5\n",
      "  2q23.1: 2\n",
      "  DOORS: 1\n",
      "  Hooft: 1\n",
      "  Basedow's: 1\n",
      "  mesangial: 1\n",
      "  Febuxostat: 1\n",
      "  avascular: 2\n",
      "  Peters: 2\n",
      "  TIMM8A: 1\n",
      "  osteoporosis-oculocutaneous: 1\n",
      "  neuroleptic: 1\n",
      "  permanent: 2\n",
      "  myelodysplasia,: 1\n",
      "  bronchus: 1\n",
      "  Mixed: 1\n",
      "  paroxysmal: 3\n",
      "  COL4A5: 1\n",
      "  Sezary: 1\n",
      "  PAX3: 1\n",
      "  non-eruption: 1\n",
      "  Indinavir: 1\n",
      "  anorectal: 1\n",
      "  Gordon: 2\n",
      "  Temozolomide: 1\n",
      "  oculoauriculovertebral: 1\n",
      "  oculo-palato-cerebral: 1\n",
      "  hamel: 1\n",
      "  Achard-Thiers: 1\n",
      "  8q24.3: 1\n",
      "  subcutaneous: 2\n",
      "  Short: 6\n",
      "  proteasome-associated: 1\n",
      "  aneurysm-osteoarthritis: 1\n",
      "  Mitchell-Riley: 1\n",
      "  pancreatic: 6\n",
      "  Acrootoocular: 1\n",
      "  RRM2B: 1\n",
      "  Greig: 1\n",
      "  specific: 2\n",
      "  Rescinnamine: 1\n",
      "  cholestasis-pigmentary: 1\n",
      "  Mifamurtide: 1\n",
      "  beta-thalassemia: 1\n",
      "  amyloidosis: 1\n",
      "  vagina: 1\n",
      "  Emtricitabine: 1\n",
      "  butyrylcholinesterase: 1\n",
      "  Bart-Pumphrey: 1\n",
      "  thin: 1\n",
      "  Waardenburg: 1\n",
      "  cone-rod: 3\n",
      "  myoclonus-cerebellar: 1\n",
      "  mammary: 1\n",
      "  Fragmented: 1\n",
      "  non-24-hour: 1\n",
      "  Potocki-Lupski: 1\n",
      "  Insulin: 7\n",
      "  nail: 1\n",
      "  Sulfasalazine: 1\n",
      "  Basilicata-Akhtar: 1\n",
      "  Nefopam: 1\n",
      "  spondylo-megaepiphyseal-metaphyseal: 1\n",
      "  FLT3: 1\n",
      "  FADD-related: 1\n",
      "  SLC6A3: 1\n",
      "  Norethisterone: 1\n",
      "  brachydactyly: 4\n",
      "  Perrault: 1\n",
      "  Leukodystrophy: 1\n",
      "  erythropoietic: 1\n",
      "  idiopathic: 5\n",
      "  leukoencephalopathy,: 4\n",
      "  Felbamate: 1\n",
      "  Fluocinolone: 1\n",
      "  Zadik-Barak-Levin: 1\n",
      "  Kyphosis: 1\n",
      "  radioulnar: 3\n",
      "  myoclonus-dystonia: 1\n",
      "  Nasu-Hakola: 1\n",
      "  white: 2\n",
      "  adenosine: 2\n",
      "  microvillus: 1\n",
      "  ADAMTS5: 1\n",
      "  Pavone: 1\n",
      "  Oppenheim: 1\n",
      "  Levocarnitine: 1\n",
      "  PJVK: 1\n",
      "  pachygyria,: 1\n",
      "  perineural: 1\n",
      "  Turcot: 1\n",
      "  Zonisamide: 1\n",
      "  Lichtenstein-Knorr: 1\n",
      "  Travoprost: 1\n",
      "  large: 1\n",
      "  aurocephalosyndactyly: 1\n",
      "  fountain: 1\n",
      "  Gadopentetic: 1\n",
      "  Ackerman: 1\n",
      "  Muscular: 1\n",
      "  Seckel: 2\n",
      "  Dahlberg-Borer-Newcomer: 1\n",
      "  sickle: 1\n",
      "  Nizatidine: 1\n",
      "  liver: 2\n",
      "  Benazepril: 1\n",
      "  femoral-facial: 1\n",
      "  erythema: 1\n",
      "  Sabinas: 1\n",
      "  late-adult: 1\n",
      "  Eisenmenger: 1\n",
      "  letterer-Siwe: 1\n",
      "  Friedreich: 1\n",
      "  dermoid: 1\n",
      "  Localized: 2\n",
      "  Nilutamide: 1\n",
      "  Menke-Hennekam: 1\n",
      "  STT3B-CDG: 1\n",
      "  purine: 1\n",
      "  tetraamelia: 2\n",
      "  Trifluoperazine: 1\n",
      "  thiamine-responsive: 1\n",
      "  Constriction: 1\n",
      "  DDC: 1\n",
      "  odontomicronychial: 1\n",
      "  Coffin-Siris: 1\n",
      "  craniosynostosis-intellectual: 2\n",
      "  5q35: 1\n",
      "  Brunsting-Perry: 1\n",
      "  dupont: 1\n",
      "  ophthalmomandibulomelic: 1\n",
      "  Fesoterodine: 1\n",
      "  laryngo-onycho-cutaneous: 1\n",
      "  trichomegaly-retina: 1\n",
      "  SCGB2A2: 1\n",
      "  yellow: 1\n",
      "  Carious: 1\n",
      "  epiphyseal: 3\n",
      "  cerebellar,: 1\n",
      "  Thiel-Behnke: 1\n",
      "  hyper-ige: 1\n",
      "  Meckel: 2\n",
      "  second: 1\n",
      "  Feeding: 2\n",
      "  Straight: 1\n",
      "  medulloblastoma: 1\n",
      "  Alstrom: 1\n",
      "  phenobarbital: 1\n",
      "  mismatch: 1\n",
      "  respiratory: 3\n",
      "  corticosterone: 2\n",
      "  Intestinal: 1\n",
      "  FGFR3: 1\n",
      "  Melnick-Needles: 1\n",
      "  Wiskott-Aldrich: 3\n",
      "  phagocytosis,: 1\n",
      "  sweet: 1\n",
      "  SHOX-related: 1\n",
      "  essential: 1\n",
      "  nasal: 2\n",
      "  Chuvash: 1\n",
      "  nephrotic: 3\n",
      "  Rizatriptan: 1\n",
      "  d-bifunctional: 1\n",
      "  Say-field-Coldwell: 1\n",
      "  Gabriele: 1\n",
      "  MIR192: 1\n",
      "  Rifaximin: 1\n",
      "  overgrowth-macrocephaly-facial: 1\n",
      "  Estazolam: 1\n",
      "  Mycophenolic: 1\n",
      "  Kyphoscoliosis: 1\n",
      "  trichohepatoneurodevelopmental: 1\n",
      "  Larsen-like: 2\n",
      "  red: 2\n",
      "  rolandic: 2\n",
      "  drug-induced: 1\n",
      "  MN1: 1\n",
      "  hyperlexia: 1\n",
      "  foveal: 1\n",
      "  Undulate: 2\n",
      "  autism,: 2\n",
      "  Profuse: 1\n",
      "  dominant: 2\n",
      "  ectrodactyly,: 1\n",
      "  lazy: 1\n",
      "  Dexketoprofen: 1\n",
      "  hyperlipoproteinemia,: 1\n",
      "  colobomata: 1\n",
      "  splenoportal: 1\n",
      "  neurofibromatosis: 2\n",
      "  Kluver-Bucy: 1\n",
      "  Camptodactyly: 3\n",
      "  Creutzfeldt: 1\n",
      "  Ursodeoxycholic: 1\n",
      "  Danon: 1\n",
      "  Aphalangy-hemivertebrae-urogenital-intestinal: 1\n",
      "  peeling: 2\n",
      "  Low: 2\n",
      "  schneckenbecken: 1\n",
      "  cardioencephalomyopathy: 1\n",
      "  Leflunomide: 1\n",
      "  thoracolaryngopelvic: 1\n",
      "  Carnevale: 1\n",
      "  ADAMTSL2: 1\n",
      "  frontoocular: 1\n",
      "  Clopidogrel: 1\n",
      "  Heart: 1\n",
      "  hyperinsulinism: 4\n",
      "  lipodystrophy: 2\n",
      "  11q22.2q22.3: 1\n",
      "  hyperammonemic: 1\n",
      "  Nezelof: 1\n",
      "  Orange: 1\n",
      "  Galantamine: 1\n",
      "  fucosidosis: 1\n",
      "  vasculitis: 1\n",
      "  sclerocornea: 1\n",
      "  obesity-hypoventilation: 1\n",
      "  Acetylcholine: 1\n",
      "  CDH23: 1\n",
      "  Topotecan: 1\n",
      "  Granisetron: 1\n",
      "  Ebstein: 1\n",
      "  acrocallosal: 1\n",
      "  Ziconotide: 1\n",
      "  Pugilistic: 1\n",
      "  GJB6: 1\n",
      "  juvenile-onset: 1\n",
      "  microcephaly-cardiomyopathy: 1\n",
      "  channelopathy-associated: 1\n",
      "  mucosulfatidosis: 1\n",
      "  L-ferritin: 1\n",
      "  ameloonychohypohidrotic: 1\n",
      "  Cooper-Jabs: 1\n",
      "  carnitine-acylcarnitine: 1\n",
      "  MAPT: 1\n",
      "  Gorham: 1\n",
      "  brachydactyly-arterial: 1\n",
      "  Morphine: 1\n",
      "  Thiemann: 1\n",
      "  20p12.3: 1\n",
      "  Mungan: 1\n",
      "  Hall-Riggs: 1\n",
      "  fibromyalgia: 1\n",
      "  D-glyceric: 1\n",
      "  2-methylbutyryl-CoA: 1\n",
      "  microcephaly-cleft: 1\n",
      "  eosinophilic: 1\n",
      "  agammaglobulinemia: 1\n",
      "  MARVELD2: 1\n",
      "  carboxypeptidase: 1\n",
      "  Billet: 1\n",
      "  pelvis-shoulder: 1\n",
      "  Delavirdine: 1\n",
      "  muscle-eye-brain: 1\n",
      "  CLDN14: 1\n",
      "  vesicoureteral: 1\n",
      "  Sparfloxacin: 1\n",
      "  Pregabalin: 1\n",
      "  Oxaprozin: 1\n",
      "  recombinant: 1\n",
      "  hirsutism-skeletal: 1\n",
      "  DYRK1A-related: 2\n",
      "  Tatsumi: 1\n",
      "  nodular: 2\n",
      "  Argatroban: 1\n",
      "  fibrosclerosis,: 1\n",
      "  LETM1: 1\n",
      "  tarp: 1\n",
      "  sialidosis: 1\n",
      "  PPARA: 1\n",
      "  wild: 1\n",
      "  auriculocondylar: 1\n",
      "  pure: 1\n",
      "  Postnatal: 2\n",
      "  Samson-Viljoen: 1\n",
      "  ataxia-telangiectasia: 1\n",
      "  self-healing: 1\n",
      "  Prednisone: 1\n",
      "  GSDME: 1\n",
      "  Tolchin-Le: 1\n",
      "  Fabry: 1\n",
      "  Fuchs': 1\n",
      "  thalidomide: 1\n",
      "  craniofrontonasal: 3\n",
      "  Camurati-Engelmann: 1\n",
      "  obesity: 6\n",
      "  Cough: 1\n",
      "  sinoatrial: 1\n",
      "  monosomy: 4\n",
      "  coloboma,: 2\n",
      "  monosodium: 1\n",
      "  Miyoshi: 1\n",
      "  Brugada: 1\n",
      "  dermo-odonto: 1\n",
      "  Cenani-Lenz: 1\n",
      "  lymphedema-atrial: 1\n",
      "  MGAT2-CDG: 1\n",
      "  ornithine: 3\n",
      "  Costello: 1\n",
      "  cardiomelic: 1\n",
      "  Midclavicular: 1\n",
      "  coarse: 1\n",
      "  ectrodactyly-polydactyly: 1\n",
      "  hip: 1\n",
      "  paraneoplastic: 1\n",
      "  Developmental: 1\n",
      "  PERCHING: 1\n",
      "  transient: 4\n",
      "  chondroectodermal: 1\n",
      "  Carey-Fineman-Ziter: 1\n",
      "  incontinentia: 1\n",
      "  inclusion: 2\n",
      "  ichthyosis-hepatosplenomegaly-cerebellar: 1\n",
      "  Sammartino-Decreccio: 1\n",
      "  Borjeson-Forssman-Lehmann: 1\n",
      "  Retinal: 2\n",
      "  Limb: 1\n",
      "  diarrhea-vomiting: 1\n",
      "  adult: 3\n",
      "  symptomatic: 1\n",
      "  extrahepatic: 1\n",
      "  goldstein: 1\n",
      "  BCL2: 1\n",
      "  Ambrisentan: 1\n",
      "  Rimexolone: 1\n",
      "  Sjogren-Larsson-like: 1\n",
      "  MSL3: 1\n",
      "  Yunis-Varon: 1\n",
      "  Shashi-Pena: 1\n",
      "  Brown-Sequard: 1\n",
      "  encephalomalacia,: 1\n",
      "  Propafenone: 1\n",
      "  mesoaxial: 2\n",
      "  non-progressive: 1\n",
      "  merlob: 1\n",
      "  baker: 1\n",
      "  angiomatosis,: 1\n",
      "  ectopia: 2\n",
      "  epidermodysplasia: 2\n",
      "  lateral: 2\n",
      "  DiGeorge: 1\n",
      "  continuous: 2\n",
      "  polyendocrine-polyneuropathy: 1\n",
      "  Death: 1\n",
      "  bone: 4\n",
      "  superficial: 1\n",
      "  oculotrichoanal: 1\n",
      "  Williams: 1\n",
      "  epilepsy-microcephaly-skeletal: 1\n",
      "  Bexarotene: 1\n",
      "  Myhre: 1\n",
      "  Lafora: 1\n",
      "  Caffeine: 1\n",
      "  Ioxaglic: 1\n",
      "  hyperargininemia: 1\n",
      "  OTOF: 1\n",
      "  male: 2\n",
      "  Azithromycin: 1\n",
      "  GHRL: 1\n",
      "  posterior: 6\n",
      "  dermotrichic: 1\n",
      "  inflammatory: 3\n",
      "  Hyperlordosis: 1\n",
      "  6q16: 1\n",
      "  microcephaly: 3\n",
      "  hyperlysinemia: 2\n",
      "  CDH2: 1\n",
      "  Long: 2\n",
      "  5q14.3: 1\n",
      "  Leigh-like: 1\n",
      "  Pergolide: 1\n",
      "  platelet: 2\n",
      "  Metronidazole: 1\n",
      "  myostatin-related: 1\n",
      "  dimethylglycine: 1\n",
      "  TELO2-related: 1\n",
      "  surfactant: 1\n",
      "  hydroxyprolinemia: 1\n",
      "  gershinibaruch: 1\n",
      "  spontaneous: 1\n",
      "  Hypoplasia: 2\n",
      "  Eplerenone: 1\n",
      "  cardiocutaneous: 1\n",
      "  Nefazodone: 1\n",
      "  methemoglobin: 1\n",
      "  DEND: 1\n",
      "  uveal: 1\n",
      "  RAB23-related: 1\n",
      "  pentasomy: 1\n",
      "  circumscribed: 2\n",
      "  DIABLO: 1\n",
      "  Cholestyramine: 1\n",
      "  Dementia: 1\n",
      "  rheumatic: 1\n",
      "  Pierson: 1\n",
      "  radial: 2\n",
      "  band: 2\n",
      "  Beaded: 1\n",
      "  POU3F4: 1\n",
      "  ear: 1\n",
      "  Paricalcitol: 1\n",
      "  Hemiplegia/hemiparesis: 1\n",
      "  Blount: 1\n",
      "  NAD(P)HX: 1\n",
      "  hypotrichosis-intellectual: 1\n",
      "  Pai: 1\n",
      "  Age: 1\n",
      "  diencephalic: 1\n",
      "  pseudoprogeria: 1\n",
      "  Ogden: 1\n",
      "  megalencephaly-capillary: 1\n",
      "  Acamprosate: 1\n",
      "  Spondylospinal: 1\n",
      "  Dexmethylphenidate: 1\n",
      "  Behavioral: 1\n",
      "  Submucous: 1\n",
      "  Tretinoin: 1\n",
      "  megalencephaly-severe: 1\n",
      "  gelatinous: 1\n",
      "  PLAU: 1\n",
      "  intracranial: 1\n",
      "  Reserpine: 1\n",
      "  Poland: 1\n",
      "  subclavian: 1\n",
      "  spermatogenic: 2\n",
      "  dracunculiasis: 1\n",
      "  tooth: 2\n",
      "  Beckwith-Wiedemann: 1\n",
      "  Landau-Kleffner: 1\n",
      "  Worster-Drought: 1\n",
      "  hypopigmentation: 1\n",
      "  Fine,: 1\n",
      "  Rib: 4\n",
      "  Granulovacuolar: 1\n",
      "  Cole-Carpenter: 1\n",
      "  acrocardiofacial: 1\n",
      "  Liberfarb: 1\n",
      "  neuromuscular: 1\n",
      "  Modafinil: 1\n",
      "  aphonia-deafness-retinal: 1\n",
      "  Levocetirizine: 1\n",
      "  Glatiramer: 1\n",
      "  criss-cross: 1\n",
      "  PUS7: 1\n",
      "  neurofibroma: 1\n",
      "  Banti: 1\n",
      "  Tenorio: 1\n",
      "  Xq25: 1\n",
      "  IGF2: 1\n",
      "  Ginkgo: 1\n",
      "  Wyburn-Mason: 1\n",
      "  osteopetrosis: 1\n",
      "  47,XYY: 1\n",
      "  carnosinemia: 1\n",
      "  Al: 1\n",
      "  cheilitis: 1\n",
      "  treacher: 1\n",
      "  snijders: 2\n",
      "  GOMBO: 1\n",
      "  Paroxetine: 1\n",
      "  amyotrophic: 4\n",
      "  pediatric: 1\n",
      "  Buserelin: 1\n",
      "  Amish: 1\n",
      "  diarrhea: 3\n",
      "  tricho-dento-osseous: 1\n",
      "  Melanocytic: 1\n",
      "  craniostenosis: 1\n",
      "  colobomatous: 3\n",
      "  Fraser-like: 1\n",
      "  bile: 1\n",
      "  ADan: 1\n",
      "  peroneus: 1\n",
      "  pineocytoma: 1\n",
      "  corneal: 8\n",
      "  Prader-Willi: 7\n",
      "  Antley-Bixler: 3\n",
      "  DOCK2: 1\n",
      "  Ahumada: 1\n",
      "  Coarse: 2\n",
      "  chylomicron: 1\n",
      "  Cilazapril: 1\n",
      "  Schinzel-Giedion: 1\n",
      "  periodic: 1\n",
      "  acalvaria: 1\n",
      "  arakawa: 1\n",
      "  thyrotoxicosis: 1\n",
      "  malignant: 1\n",
      "  WFS1: 1\n",
      "  heterotaxy,: 2\n",
      "  McDonough: 1\n",
      "  hypermethioninemia: 1\n",
      "  Lercanidipine: 1\n",
      "  Behr: 1\n",
      "  thrombocythemia: 1\n",
      "  laryngotracheal: 1\n",
      "  metatropic: 1\n",
      "  non-spherocytic: 1\n",
      "  Filippi: 1\n",
      "  CCDC115-CDG: 1\n",
      "  oculocerebrocutaneous: 1\n",
      "  Bernard-Soulier: 2\n",
      "  fatal: 2\n",
      "  pseudoaminopterin: 1\n",
      "  cirrhosis: 1\n",
      "  Omeprazole: 1\n",
      "  conotruncal: 1\n",
      "  imperforate: 2\n",
      "  toluene: 1\n",
      "  myoclonic-astastic: 1\n",
      "  Atropine: 1\n",
      "  Acetabular: 1\n",
      "  dysmorphism: 1\n",
      "  RPE65: 1\n",
      "  ATN1: 1\n",
      "  tropical: 2\n",
      "  long: 3\n",
      "  Beclomethasone: 1\n",
      "  antisynthetase: 1\n",
      "  Norum: 1\n",
      "  herpes: 1\n",
      "  psychomotor: 2\n",
      "  Mitotane: 1\n",
      "  Schwartz-Cohen-addad-Lambert: 1\n",
      "  lymphatic: 1\n",
      "  Lomefloxacin: 1\n",
      "  ALDH1B1: 1\n",
      "  VIPoma: 1\n",
      "  Lown-Ganong-Levine: 1\n",
      "  Tenofovir: 1\n",
      "  Irbesartan: 1\n",
      "  hydrocephalus-obesity-hypogonadism: 1\n",
      "  sorbitol: 1\n",
      "  Jacobsen: 1\n",
      "  Flunisolide: 1\n",
      "  beta-thalassemia-X-linked: 1\n",
      "  lead: 1\n",
      "  osteomesopyknosis: 1\n",
      "  Bjornstad: 1\n",
      "  neutral: 1\n",
      "  isovaleric: 2\n",
      "  oculoauricular: 1\n",
      "  Acitretin: 1\n",
      "  lipodystrophy-intellectual: 1\n",
      "  fragile: 2\n",
      "  Laurence-Prosser-Rocker: 1\n",
      "  tetralogy: 1\n",
      "  Kniest: 1\n",
      "  Gamstorp-Wohlfart: 1\n",
      "  cyclic: 1\n",
      "  oculodentodigital: 2\n",
      "  cataract-nephropathy-encephalopathy: 1\n",
      "  spondylocarpotarsal: 1\n",
      "  Restricted: 3\n",
      "  SYNGAP1-related: 1\n",
      "  oculomaxillofacial: 1\n",
      "  brachydactyly-preaxial: 1\n",
      "  48,XXYY: 1\n",
      "  adrenocortical: 1\n",
      "  Salmon: 1\n",
      "  bobble-head: 1\n",
      "  Epiphyseal: 4\n",
      "  hypotrichosis: 1\n",
      "  camptomelic: 1\n",
      "  Phelan-McDermid: 1\n",
      "  SLC33A1: 1\n",
      "  LMNA-related: 1\n",
      "  DSCAM: 1\n",
      "  exudative: 1\n",
      "  Sitaxentan: 1\n",
      "  EYA4: 1\n",
      "  indolent: 1\n",
      "  ataxia,: 2\n",
      "  sea-blue: 1\n",
      "  muscle: 3\n",
      "  Chronic: 3\n",
      "  pointer: 1\n",
      "  prolidase: 1\n",
      "  Huntington: 3\n",
      "  Kennedy: 1\n",
      "  Small,: 1\n",
      "  CHARGE: 1\n",
      "  Wolman: 2\n",
      "  Parkinson: 1\n",
      "  osteopenia-intellectual: 1\n",
      "  epimetaphyseal: 1\n",
      "  apparent: 1\n",
      "  midface: 2\n",
      "  Morbus: 1\n",
      "  WAGR: 1\n",
      "  Finasteride: 1\n",
      "  Luscan-Lumish: 1\n",
      "  Silver: 2\n",
      "  hypohidrosis: 1\n",
      "  Foscarnet: 1\n",
      "  Rod-cone: 1\n",
      "  ribose-5-P: 1\n",
      "  progeria-short: 1\n",
      "  Pierpont: 1\n",
      "  fatty: 2\n",
      "  trimethylaminuria: 1\n",
      "  3-hydroxy-3-methylglutaric: 1\n",
      "  dobrow: 1\n",
      "  PANDAS: 1\n",
      "  Pierre: 2\n",
      "  Oseltamivir: 1\n",
      "  pyknoachondrogenesis: 1\n",
      "  Oxcarbazepine: 1\n",
      "  IVIC: 1\n",
      "  AP4-related: 1\n",
      "  hallux: 1\n",
      "  Hernia: 2\n",
      "  seizures-scoliosis-macrocephaly: 1\n",
      "  persian: 1\n",
      "  preeclampsia: 1\n",
      "  Glyburide: 1\n",
      "  granulomatosis: 1\n",
      "  mucopolysaccharidosis: 1\n",
      "  Buschke-Ollendorff: 1\n",
      "  Almotriptan: 1\n",
      "  methylcobalamin: 2\n",
      "  empty: 1\n",
      "  Spondyloenchondrodysplasia: 1\n",
      "  Ritscher-Schinzel: 1\n",
      "  Atrophy/Degeneration: 1\n",
      "  eyelids: 1\n",
      "  Large: 3\n",
      "  Mauriac: 1\n",
      "  Upper: 2\n",
      "  chondrocalcinosis: 1\n",
      "  Weill-Marchesani: 1\n",
      "  Levetiracetam: 1\n",
      "  Nicardipine: 1\n",
      "  extrasystoles: 1\n",
      "  fish: 1\n",
      "  Optic: 1\n",
      "  C1-C2: 2\n",
      "  Birk-Barel: 1\n",
      "  immunodeficiency: 12\n",
      "  CBL-related: 1\n",
      "  Galsulfase: 1\n",
      "  Perioral: 1\n",
      "  adult-onset: 6\n",
      "  IGKC: 1\n",
      "  lessel-kubisch: 1\n",
      "  CLRN1: 1\n",
      "  46,XX: 3\n",
      "  Schilbach-Rott: 1\n",
      "  Amiodarone: 1\n",
      "  Vertebral: 3\n",
      "  symphalangism: 2\n",
      "  Renpenning: 1\n",
      "  ulna: 2\n",
      "  Flexion: 2\n",
      "  MYPN-related: 1\n",
      "  Friedman: 1\n",
      "  Levofloxacin: 1\n",
      "  spleen: 1\n",
      "  NTF4: 1\n",
      "  bird: 1\n",
      "  Jaberi-Elahi: 1\n",
      "  cataract,: 1\n",
      "  branchiooculofacial: 1\n",
      "  dysosteosclerosis: 1\n",
      "  AHDC1-related: 1\n",
      "  kyphoscoliotic: 1\n",
      "  3-hydroxy-3-methylglutaryl-CoA: 1\n",
      "  Boerhaave: 1\n",
      "  SLC4A4: 1\n",
      "  mevalonic: 1\n",
      "  psoriasis: 1\n",
      "  cardiomyopathy-cataract-hip: 1\n",
      "  Pentostatin: 1\n",
      "  Scapulohumeral: 1\n",
      "  hidrotic: 1\n",
      "  Axenfeld-Rieger: 2\n",
      "  feigenbaum: 1\n",
      "  dermatoosteolysis,: 1\n",
      "  Salla: 1\n",
      "  hyperlysinuria: 1\n",
      "  sarcoidosis: 1\n",
      "  Majeed: 1\n",
      "  EEC: 1\n",
      "  SERKAL: 1\n",
      "  arena: 1\n",
      "  Frasier: 1\n",
      "  ethanolaminosis: 1\n",
      "  acetyl-coa: 1\n",
      "  scapuloperoneal: 1\n",
      "  Sertraline: 1\n",
      "  MAFF: 1\n",
      "  heme: 1\n",
      "  Webb-Dattani: 1\n",
      "  Brinzolamide: 1\n",
      "  micrognathia-recurrent: 1\n",
      "  dysmorphism-conductive: 1\n",
      "  microlissencephaly-micromelia: 1\n",
      "  Posaconazole: 1\n",
      "  limited: 1\n",
      "  phosphoenolpyruvate: 2\n",
      "  chromosomal: 1\n",
      "  Gollop-Wolfgang: 1\n",
      "  Tetryzoline: 1\n",
      "  48,XYYY: 1\n",
      "  homozygous: 2\n",
      "  dopamine: 2\n",
      "  blepharophimosis: 4\n",
      "  collagenopathy: 1\n",
      "  9p13: 1\n",
      "  Ephedrine: 1\n",
      "  PNPT1: 1\n",
      "  Moxifloxacin: 1\n",
      "  precocious: 1\n",
      "  Pioglitazone: 1\n",
      "  Bowen: 1\n",
      "  Clofarabine: 1\n",
      "  multiminicore: 1\n",
      "  riboflavin: 1\n",
      "  Jackson-Weiss: 1\n",
      "  reticular: 1\n",
      "  acitretin/etretinate: 1\n",
      "  Bethlem: 1\n",
      "  holoprosencephaly-caudal: 1\n",
      "  Tako-tsubo: 1\n",
      "  PRPS1: 1\n",
      "  relapsing: 1\n",
      "  oculotrichodysplasia: 1\n",
      "  ichthyosis-short: 1\n",
      "  monogenic: 1\n",
      "  IQSEC1: 1\n",
      "  Sugarman: 1\n",
      "  hypertrichosis: 2\n",
      "  pyogenic: 2\n",
      "  oculocerebrodental: 1\n",
      "  STAT1: 1\n",
      "  Lichtenstein: 1\n",
      "  choroid: 1\n",
      "  Periarticular: 1\n",
      "  PCWH: 1\n",
      "  Coffin-Lowry: 1\n",
      "  Diaphyseal: 3\n",
      "  digitotalar: 2\n",
      "  LEP: 1\n",
      "  NOS1: 1\n",
      "  Protamine: 1\n",
      "  preaxial: 1\n",
      "  weiss-kruszka: 1\n",
      "  Sunitinib: 1\n",
      "  enterocolitis: 1\n",
      "  macrocephaly/megalencephaly: 1\n",
      "  tethered: 1\n",
      "  Impulsivity: 1\n",
      "  odontotrichomelic: 1\n",
      "  TMC1: 1\n",
      "  trigonocephaly-bifid: 1\n",
      "  deafness-oligodontia: 1\n",
      "  tufted: 1\n",
      "  brittle: 2\n",
      "  NOS3: 1\n",
      "  Oguchi: 1\n",
      "  Hydralazine: 1\n",
      "  Gadoxetic: 1\n",
      "  acromelic: 1\n",
      "  arrhythmogenic: 2\n",
      "  oral: 2\n",
      "  holoprosencephaly-craniosynostosis: 1\n",
      "  Pfeiffer-Palm-Teller: 1\n",
      "  ALG9-CDG: 1\n",
      "  macrocephaly-developmental: 1\n",
      "  Char: 1\n",
      "  adipose: 2\n",
      "  Fontaine: 1\n",
      "  Jeune: 1\n",
      "  macrothrombocytopenia: 1\n",
      "  Warburg: 1\n",
      "  hyper-beta-alaninemia: 1\n",
      "  BNAR: 1\n",
      "  platyspondylic: 1\n",
      "  Tamoxifen: 1\n",
      "  Nitazoxanide: 1\n",
      "  Disproportionate: 2\n",
      "  Kikuchi-Fujimoto: 1\n",
      "  aluminosis: 1\n",
      "  SERAC1: 1\n",
      "  Zalcitabine: 1\n",
      "  cardiomyopathy: 6\n",
      "  microcornea-myopic: 1\n",
      "  Imatinib: 1\n",
      "  Cushing: 3\n",
      "  Darunavir: 1\n",
      "  dwarfism: 5\n",
      "  BH4-deficient: 1\n",
      "  rectum: 1\n",
      "  SLC35A2-CDG: 1\n",
      "  dengue: 1\n",
      "  Hyper-IgE: 1\n",
      "  CDCA7: 1\n",
      "  hypotrichosis-lymphedema-telangiectasia: 1\n",
      "  LSS: 1\n",
      "  Johnson: 1\n",
      "  type: 2\n",
      "  thumb: 2\n",
      "  Sprengel: 1\n",
      "  Dolichocephaly: 1\n",
      "  CYP1B1: 1\n",
      "  Opticocochleodentate: 1\n",
      "  Contracture: 4\n",
      "  N: 1\n",
      "  RSPH4A: 1\n",
      "  N-acetylaspartate: 1\n",
      "  ablepharon: 1\n",
      "  acrodermatitis: 1\n",
      "  GOT2: 1\n",
      "  hyperzincemia: 1\n",
      "  myometrium: 1\n",
      "  FGF3: 1\n",
      "  asphyxiating: 1\n",
      "  immunodeficiency,: 3\n",
      "  microcephaly-cardiac: 1\n",
      "  LADD: 1\n",
      "  acromegaloid: 1\n",
      "  homocystinuria: 2\n",
      "  FGF12: 1\n",
      "  enlarged: 1\n",
      "  pleoconial: 1\n",
      "  Dohle: 1\n",
      "  Sodium: 1\n",
      "  Ectopic: 1\n",
      "  crawfurd: 1\n",
      "  Ergocalciferol: 1\n",
      "  Hoffmann: 1\n",
      "  hypospadias-intellectual: 1\n",
      "  PPoma: 1\n",
      "  ankyloblepharon: 1\n",
      "  aggressive: 1\n",
      "  Cyclophosphamide: 1\n",
      "  DNMT1: 1\n",
      "  human: 2\n",
      "  hemangiopericytoma,: 1\n",
      "  Melkersson-Rosenthal: 1\n",
      "  tetragametic: 1\n",
      "  Repaglinide: 1\n",
      "  porokeratosis: 1\n",
      "  Weismann-Netter: 1\n",
      "  thickened: 1\n",
      "  polyarteritis: 1\n",
      "  gingival: 3\n",
      "  Lansoprazole: 1\n",
      "  Schmorl's: 1\n",
      "  IFAP: 1\n",
      "  die: 2\n",
      "  subcortical: 1\n",
      "  megalencephaly: 2\n",
      "  alpha-methylacyl-CoA: 1\n",
      "  lentiginosis,: 1\n",
      "  enamel: 2\n",
      "  Biconcave: 2\n",
      "  Ixabepilone: 1\n",
      "  VACTERL/vater: 1\n",
      "  ATP6V1B1: 1\n",
      "  duodenal: 2\n",
      "  ankylosis: 1\n",
      "  Meniere: 1\n",
      "  postencephalitic: 1\n",
      "  KRT14-related: 1\n",
      "  SUNCT: 1\n",
      "  lipoyl: 1\n",
      "  Olmsted: 1\n",
      "  2q24: 1\n",
      "  Metipranolol: 1\n",
      "  fever,: 1\n",
      "  9q31.1q31.3: 1\n",
      "  somatomammotropinoma: 1\n",
      "  PHARC: 1\n",
      "  Sturge-Weber: 1\n",
      "  attenuated: 2\n",
      "  SAPHO: 1\n",
      "  SLC35A1-CDG: 1\n",
      "  Hb: 1\n",
      "  centra: 1\n",
      "  craniopharyngioma: 1\n",
      "  cortada: 1\n",
      "  ESPN: 1\n",
      "  Fluticasone: 2\n",
      "  hyperphosphatemia,: 1\n",
      "  tall: 2\n",
      "  Brunner: 1\n",
      "  anhidrosis,: 1\n",
      "  Vinflunine: 1\n",
      "  DSPP: 1\n",
      "  Aicardi-Goutieres: 1\n",
      "  pyridoxal: 1\n",
      "  Spasticity: 1\n",
      "  bagatelle: 1\n",
      "  osteoarthritis: 1\n",
      "  IGFALS: 1\n",
      "  acrodysostosis: 2\n",
      "  Gemignani: 1\n",
      "  Warsaw: 1\n",
      "  Wolff-Parkinson-white: 1\n",
      "  ethylmalonic: 1\n",
      "  Potocki-Shaffer: 1\n",
      "  disseminated: 1\n",
      "  Partington: 1\n",
      "  SLC29A3: 1\n",
      "  Vigabatrin: 1\n",
      "  Dasatinib: 1\n",
      "  Tiagabine: 1\n",
      "  mal: 1\n",
      "  SLC26A5: 1\n",
      "  phenylketonuria: 1\n",
      "  Etonogestrel: 1\n",
      "  Dorzolamide: 1\n",
      "  deafness-infertility: 1\n",
      "  ichthyosis: 2\n",
      "  hypoxanthine: 1\n",
      "  trigeminal: 1\n",
      "  Didanosine: 1\n",
      "  intrinsic: 1\n",
      "  Okur-Chung: 1\n",
      "  contractures-ectodermal: 1\n",
      "  normal: 1\n",
      "  pancytopenia-developmental: 1\n",
      "  46: 1\n",
      "  lathosterolosis: 1\n",
      "  siddiqi: 1\n",
      "  hyperostosis: 2\n",
      "  FANCC: 1\n",
      "  5-oxoprolinase: 1\n",
      "  carpo: 1\n",
      "  presynaptic: 1\n",
      "  congenitally: 1\n",
      "  Entecavir: 1\n",
      "  Methylergometrine: 1\n",
      "  isotretinoin-like: 1\n",
      "  Aarskog-Scott: 1\n",
      "  rhizomelic: 3\n",
      "  uridine-cytidineuria: 1\n",
      "  MALT: 1\n",
      "  Sotalol: 1\n",
      "  Pantoprazole: 1\n",
      "  piepkorn: 1\n",
      "  Aase-Smith: 1\n",
      "  osteodysplasty,: 1\n",
      "  Bangstad: 1\n",
      "  inosine: 1\n",
      "  Poirier-Bienvenu: 1\n",
      "  mucous: 1\n",
      "  structural: 2\n",
      "  rabies: 1\n",
      "  Heparin: 1\n",
      "  Contractures: 1\n",
      "  Monophalangy: 1\n",
      "  nephropathy,: 1\n",
      "  Tramadol: 1\n",
      "  Gardner: 1\n",
      "  PCDH15: 1\n",
      "  SLC39A8-CDG: 1\n",
      "  glutathione: 2\n",
      "  ichthyosis-intellectual: 2\n",
      "  Mayer-Rokitansky-Kuster-Hauser: 1\n",
      "  Numerous: 1\n",
      "  EEM: 1\n",
      "  hemangioblastoma: 1\n",
      "  multi-cellular: 1\n",
      "  Salicylic: 1\n",
      "  Keipert: 1\n",
      "  cloacal: 1\n",
      "  dyschromatosis: 1\n",
      "  Emery-Dreifuss: 1\n",
      "  Mefloquine: 1\n",
      "  Hydrocodone: 1\n",
      "  CDK8: 1\n",
      "  torsion: 1\n",
      "  platelet-activating: 1\n",
      "  PHGDH: 1\n",
      "  SALL4: 1\n",
      "  Czeizel-Losonci: 1\n",
      "  subaortic: 2\n",
      "  STAG2: 1\n",
      "  septopreoptic: 1\n",
      "  anosmia: 2\n",
      "  Cayman: 1\n",
      "  Amikacin: 1\n",
      "  Telavancin: 1\n",
      "  cerebelloparenchymal: 1\n",
      "  Sackey-Sakati-Aur: 1\n",
      "  oculodental: 1\n",
      "  Knobloch: 1\n",
      "  Susac: 1\n",
      "  Malan: 1\n",
      "  layer: 1\n",
      "  alopecia-epilepsy-pyorrhea-intellectual: 1\n",
      "  MELAS: 1\n",
      "  neurodegenerative: 1\n",
      "  syndrome: 4\n",
      "  cognitive: 2\n",
      "  Dysphagia: 1\n",
      "  Fried's: 1\n",
      "  pantothenate: 1\n",
      "  ataxia-telangiectasia-like: 1\n",
      "  TRIM37: 1\n",
      "  odontochondrodysplasia: 1\n",
      "  McCune-Albright: 1\n",
      "  craniodigital: 1\n",
      "  Cyanocobalamin: 1\n",
      "  ichthyosis-oral: 1\n",
      "  compartment: 1\n",
      "  macrosomia: 1\n",
      "  hepatitis,: 1\n",
      "  Haloperidol: 1\n",
      "  sulfite: 1\n",
      "  Erythromycin: 1\n",
      "  osteocraniostenosis: 1\n",
      "  hiatus: 1\n",
      "  midline: 2\n",
      "  alkaptonuria: 1\n",
      "  corticosteroid-binding: 1\n",
      "  craniometadiaphyseal: 1\n",
      "  Triamcinolone: 1\n",
      "  camptobrachydactyly: 1\n",
      "  radio-renal: 1\n",
      "  maple: 1\n",
      "  Excessive: 1\n",
      "  MOGS-CDG: 1\n",
      "  hypotonia-cystinuria: 1\n",
      "  AGAT: 1\n",
      "  microform: 1\n",
      "  cleidorhizomelic: 1\n",
      "  AA: 1\n",
      "  ABAT: 1\n",
      "  encephalitis: 1\n",
      "  Sengers: 1\n",
      "  Oxandrolone: 1\n",
      "  homocarnosinosis: 1\n",
      "  hepatic: 3\n",
      "  microcephaly-microcornea: 1\n",
      "  formiminoglutamic: 1\n",
      "  pellagra-like: 1\n",
      "  Clouston: 1\n",
      "  Cardiomegaly: 1\n",
      "  inherited: 4\n",
      "  follicular: 1\n",
      "  le: 1\n",
      "  radiculoneuropathy,: 1\n",
      "  GALNS: 1\n",
      "  myofibrillar: 1\n",
      "  Cree: 1\n",
      "  SERPINB6: 1\n",
      "  Bardet-Biedl: 1\n",
      "  palmoplantar: 5\n",
      "  Fuhrmann: 1\n",
      "  axial: 2\n",
      "  pentalogy: 1\n",
      "  prenatal: 1\n",
      "  PTEN: 1\n",
      "  pubic: 1\n",
      "  LTBP3: 1\n",
      "  craniosynostosis-fibular: 1\n",
      "  portal: 1\n",
      "  Caroli: 1\n",
      "  exostoses: 1\n",
      "  Low-frequency: 1\n",
      "  Itraconazole: 1\n",
      "  FBXL3: 1\n",
      "  49,XYYYY: 1\n",
      "  hypermetabolism: 1\n",
      "  carbamoyl: 1\n",
      "  Restrictive: 2\n",
      "  Congenital: 4\n",
      "  syndactyly: 1\n",
      "  Troyer: 1\n",
      "  cardioencephalomyopathy,: 1\n",
      "  ACTG1: 1\n",
      "  MOMO: 1\n",
      "  Full: 1\n",
      "  LMX1A: 1\n",
      "  Lanreotide: 1\n",
      "  microcephaly-brachydactyly-kyphoscoliosis: 1\n",
      "  regional: 1\n",
      "  amyotonia: 1\n",
      "  PCYT2: 1\n",
      "  sick: 3\n",
      "  extensor: 1\n",
      "  phocomelia-ectrodactyly-deafness-sinus: 1\n",
      "  hemosiderosis,: 1\n",
      "  seizures,: 1\n",
      "  Aortic: 1\n",
      "  Pyle: 1\n",
      "  lower: 1\n",
      "  Baratela-Scott: 1\n",
      "  Cornelia: 1\n",
      "  Goserelin: 1\n",
      "  Bartter: 1\n",
      "  Intermittent: 1\n",
      "  Naltrexone: 1\n",
      "  Hermansky-Pudlak: 1\n",
      "  Atorvastatin: 1\n",
      "  Olanzapine: 1\n",
      "  Vinorelbine: 1\n",
      "  Silver-Russell: 1\n",
      "  lysinuric: 1\n",
      "  Sleep: 2\n",
      "  Noncompaction: 1\n",
      "  Hypertonia: 1\n",
      "  Phentermine: 1\n",
      "  pfeiffer: 1\n",
      "  whistling: 1\n",
      "  pancreas: 1\n",
      "  Aksu: 1\n",
      "  Pelger-Huet: 1\n",
      "  Stevenson-Carey: 1\n",
      "  retinoschisis: 1\n",
      "  PPARG: 1\n",
      "  Pilarowski-Bjornsson: 1\n",
      "  Xq12-q13.3: 1\n",
      "  Moynahan: 1\n",
      "  Hirschsprung: 4\n",
      "  Dextroamphetamine: 1\n",
      "  aldosterone-producing: 1\n",
      "  pectus: 1\n",
      "  Rufinamide: 1\n",
      "  PGM1-CDG: 1\n",
      "  Epoprostenol: 1\n",
      "  Good: 1\n",
      "  ATP13A2: 1\n",
      "  Satoyoshi: 1\n",
      "  holoprosencephaly-postaxial: 1\n",
      "  Levothyroxine: 1\n",
      "  Bepridil: 1\n",
      "  POLR2A: 1\n",
      "  EIF2AK1: 1\n",
      "  NARP: 1\n",
      "  ABeta2M: 1\n",
      "  Al-Raqad: 1\n",
      "  transaldolase: 1\n",
      "  Say-Barber-Miller: 1\n",
      "  OSLAM: 1\n",
      "  Toremifene: 1\n",
      "  2-aminoadipic: 1\n",
      "  infant: 1\n",
      "  SLC17A8: 1\n",
      "  Colver: 1\n",
      "  Naproxen: 1\n",
      "  polyhydramnios,: 2\n",
      "  Dennis-Fairhurst-Moore: 1\n",
      "  Neurodegeneration: 1\n",
      "  Atenolol: 1\n",
      "  ALG12-CDG: 1\n",
      "  reticuloendotheliosis,: 1\n",
      "  hyperphosphatasia: 1\n",
      "  acromegaly: 1\n",
      "  blepharo: 1\n",
      "  Lanthanum: 1\n",
      "  Interphalangeal: 1\n",
      "  Stevens-Johnson: 1\n",
      "  Crane-Heise: 1\n",
      "  Alazami-Yuan: 1\n",
      "  CRYM: 1\n",
      "  16q24.3: 1\n",
      "  encephalomyopathy,: 1\n",
      "  HELLP: 1\n",
      "  dyskinesia,: 1\n",
      "  Xp22.3: 1\n",
      "  Baller-Gerold: 1\n",
      "  Unilateral: 1\n",
      "  medial: 1\n",
      "  Generalized: 5\n",
      "  multicentric: 4\n",
      "  Ertapenem: 1\n",
      "  pyloric: 1\n",
      "  Posterior: 1\n",
      "  PYCR2-related: 1\n",
      "  Dorfman-Chanarin: 1\n",
      "  MYO7A: 1\n",
      "  myosclerosis: 1\n",
      "  neurogenic: 1\n",
      "  epidermolytic: 1\n",
      "  neurometabolic: 1\n",
      "  iatrogenic: 1\n",
      "  Fitz-Hugh-Curtis: 1\n",
      "  ETS2: 1\n",
      "  MITF: 1\n",
      "  Keutel: 1\n",
      "  G6PD: 1\n",
      "  Ritonavir: 1\n",
      "  craniofacial-deafness-hand: 1\n",
      "  LRP8: 1\n",
      "  Phenytoin: 1\n",
      "  arthrogryposis-: 1\n",
      "  Alexander: 1\n",
      "  17q21.31: 1\n",
      "  pigmented: 1\n",
      "  Regadenoson: 1\n",
      "  Narcolepsy: 1\n",
      "  Gitelman: 1\n",
      "  Say-Carpenter: 1\n",
      "  Congestive: 1\n",
      "  Koolen-de: 1\n",
      "  galactosialidosis: 1\n",
      "  GPR155: 1\n",
      "  Holmes-Adie: 1\n",
      "  volvulus: 1\n",
      "  penoscrotal: 1\n",
      "  Goldberg-Shprintzen: 1\n",
      "  aromatase: 2\n",
      "  Oxaliplatin: 1\n",
      "  Acetaminophen: 1\n",
      "  decidua: 1\n",
      "  cobblestone: 1\n",
      "  anemia,: 3\n",
      "  ADGRV1: 1\n",
      "  Colesevelam: 1\n",
      "  Roberts-SC: 1\n",
      "  Cardiac: 1\n",
      "  Tamsulosin: 1\n",
      "  corneal-cerebellar: 1\n",
      "  Reticulated: 1\n",
      "  Olopatadine: 1\n",
      "  Minoxidil: 1\n",
      "  premature: 3\n",
      "  gonadal: 2\n",
      "  brown-Vialetto-van: 1\n",
      "  DAPK2: 1\n",
      "  Garret-Tripp: 1\n",
      "  adenine: 1\n",
      "  Premature: 1\n",
      "  microcephaly-glomerulonephritis-marfanoid: 1\n",
      "  PHAVER: 1\n",
      "  aneurysm: 1\n",
      "  Piperacillin: 1\n",
      "  Stimmler: 1\n",
      "  arachnodactyly-abnormal: 1\n",
      "  Triangular: 2\n",
      "  cauda: 1\n",
      "  Etodolac: 1\n",
      "  Amphotericin: 1\n",
      "  Ketorolac: 1\n",
      "  sandestig-stefanova: 1\n",
      "  hypothyroidism: 2\n",
      "  Skeletal: 2\n",
      "  floating-Harbor: 1\n",
      "  wrinkly: 1\n",
      "  Entacapone: 1\n",
      "  nasopalpebral: 1\n",
      "  POEMS: 1\n",
      "  sideroblastic: 1\n",
      "  esophagus: 1\n",
      "  cortical: 2\n",
      "  MHC: 2\n",
      "  miliaria: 1\n",
      "  linear: 2\n",
      "  Wissler: 1\n",
      "  candidiasis,: 1\n",
      "  Atazanavir: 1\n",
      "  Fosfomycin: 1\n",
      "  split: 2\n",
      "  Wieacker-Wolff: 1\n",
      "  Tolcapone: 1\n",
      "  systemic: 2\n",
      "  RIDDLE: 1\n",
      "  bronchiectasis: 1\n",
      "  Hydromorphone: 1\n",
      "  C1Q: 1\n",
      "  endometriosis,: 1\n",
      "  Streptomycin: 1\n",
      "  9q33.3q34.11: 1\n",
      "  acetylation,: 1\n",
      "  thiopurine: 1\n",
      "  Athrombia,: 1\n",
      "  lysine: 1\n",
      "  Limitation: 3\n",
      "  WAC-related: 1\n",
      "  chondroitin: 1\n",
      "  intestinal: 3\n",
      "  Rift: 1\n",
      "  dysostosis: 1\n",
      "  amelia: 1\n",
      "  Ciclesonide: 1\n",
      "  external: 1\n",
      "  microcolon: 1\n",
      "  peripartum: 1\n",
      "  hypokalemic: 1\n",
      "  Rienhoff: 1\n",
      "  megalencephalic: 2\n",
      "  meningococcal: 1\n",
      "  Ondansetron: 1\n",
      "  CDK5R1: 1\n",
      "  macroepiphyseal: 1\n",
      "  Rothmund-Thomson: 1\n",
      "  Formoterol: 1\n",
      "  Kifafa: 1\n",
      "  JAG1: 1\n",
      "  Abdominal: 1\n",
      "  geroderma: 1\n",
      "  Zellweger: 1\n",
      "  anodontia: 1\n",
      "  Diazoxide: 1\n",
      "  rhombencephalosynapsis: 1\n",
      "  SIN3A-related: 1\n",
      "  cornea: 2\n",
      "  SPOAN: 1\n",
      "  engraftment: 1\n",
      "  Gillessen-Kaesbach-Nishimura: 1\n",
      "  unilateral: 1\n",
      "  somatostatinoma: 1\n",
      "  mental: 1\n",
      "  Leuprolide: 1\n",
      "  Meloxicam: 1\n",
      "  ATXN3: 1\n",
      "  Varenicline: 1\n",
      "  BSND: 1\n",
      "  TH: 1\n",
      "  PEPD: 1\n",
      "  Rivastigmine: 1\n",
      "  Currarino: 1\n",
      "  frontofacionasal: 1\n",
      "  hyperlipidemia: 1\n",
      "  phosphoribosylpyrophosphate: 2\n",
      "  seizures-intellectual: 1\n",
      "  uterus: 1\n",
      "  Dexamethasone: 1\n",
      "  sarcosinemia: 1\n",
      "  psoriasis-related: 1\n",
      "  TH-deficient: 1\n",
      "  adenylosuccinate: 1\n",
      "  pigmentation: 1\n",
      "  Hypersexuality: 1\n",
      "  DDOST-CDG: 1\n",
      "  MYO15A: 1\n",
      "  odonto-onycho: 1\n",
      "  asthma,: 2\n",
      "  resistance: 1\n",
      "  Vestronidase: 1\n",
      "  Shwachman-Diamond: 1\n",
      "  COCH: 1\n",
      "  Keppen-Lubinsky: 1\n",
      "  craniodiaphyseal: 2\n",
      "  Blau: 1\n",
      "  NR1I2: 1\n",
      "  microtia: 1\n",
      "  hydrocephaly-cerebellar: 1\n",
      "  zone: 1\n",
      "  Sweeney-Cox: 1\n",
      "  hypotonia-failure: 1\n",
      "  myoclonus,: 1\n",
      "  coated: 1\n",
      "  GJB2: 1\n",
      "  Cisplatin: 1\n",
      "  phenformin: 1\n",
      "  spasticity-ataxia-gait: 1\n",
      "  Small: 1\n",
      "  aniridia: 1\n",
      "  Neonatal: 1\n",
      "  omental: 1\n",
      "  Fludarabine: 1\n",
      "  femur-fibula-ulna: 1\n",
      "  NGF: 1\n",
      "  adrenomyeloneuropathy: 1\n",
      "  Poor: 1\n",
      "  Iodixanol: 1\n",
      "  Wieacker-Wolff,: 1\n",
      "  sialuria: 1\n",
      "  Krabbe: 2\n",
      "  6p22: 1\n",
      "  neuroectodermal: 1\n",
      "  acral: 2\n",
      "  Timolol: 1\n",
      "  Slender: 1\n",
      "  Catel-Manzke: 1\n",
      "  leukodystrophy: 1\n",
      "  myeloperoxidase: 1\n",
      "  Woodhouse-Sakati: 1\n",
      "  lactic: 1\n",
      "  Thin: 4\n",
      "  Nandrolone: 1\n",
      "  Mowat-Wilson: 3\n",
      "  BCL2L1: 1\n",
      "  Summitt: 1\n",
      "  disaccharide: 1\n",
      "  hyperopia,: 1\n",
      "  Netherton: 1\n",
      "  ADULT: 1\n",
      "  scleroderma: 1\n",
      "  Erlotinib: 1\n",
      "  Hypoplastic: 2\n",
      "  PMM2-CDG: 1\n",
      "  microcephaly-seizures-intellectual: 1\n",
      "  19p13.12: 1\n",
      "  Conjugated: 1\n",
      "  osteogenesis: 2\n",
      "  CHIME: 1\n",
      "  Ganciclovir: 1\n",
      "  renal-hepatic-pancreatic: 1\n",
      "  1p21.3: 1\n",
      "  IgAD1: 1\n",
      "  dicarboxylic: 1\n",
      "  14q24.1q24.3: 1\n",
      "  Sakati-Nyhan: 1\n",
      "  advanced: 1\n",
      "  Watson: 1\n",
      "  geleophysic: 1\n",
      "  urinary: 2\n",
      "  Sleep-wake: 1\n",
      "  LCAT: 1\n",
      "  Cryoglobulinemic: 1\n",
      "  NMNAT1: 1\n",
      "  Collins-Sakati: 1\n",
      "  MVP1: 1\n",
      "  Anastrozole: 1\n",
      "  KDM3B: 1\n",
      "  Kerion: 1\n",
      "  Opacification: 2\n",
      "  nemaline: 1\n",
      "  8p23.1: 2\n",
      "  glaucoma-ectopia-microspherophakia-stiff: 1\n",
      "  Mounier-Kuhn: 1\n",
      "  agyria: 1\n",
      "  USH1C: 1\n",
      "  glucose-galactose: 1\n",
      "  polyglucosan: 2\n",
      "  Mullegama-Klein-Martinez: 1\n",
      "  shone: 1\n",
      "  Meier-Gorlin: 1\n",
      "  Flucytosine: 1\n",
      "  otospondylomegaepiphyseal: 2\n",
      "  KRAS: 1\n",
      "  blepharophimosis,: 1\n",
      "  cormier: 1\n",
      "  Noonan: 3\n",
      "  anophthalmia/microphthalmia-esophageal: 1\n",
      "  hypomandibular: 1\n",
      "  duplication: 3\n",
      "  hemiparkinsonism-hemiatrophy: 1\n",
      "  Vogt-Koyanagi-Harada: 1\n",
      "  Papilledema: 1\n",
      "  Mottled: 1\n",
      "  cryptosporidiosis-chronic: 1\n",
      "  Rabeprazole: 1\n",
      "  hemidystonia-hemiatrophy: 1\n",
      "  Zaleplon: 1\n",
      "  tremor-ataxia-central: 1\n",
      "  mucocutaneous: 1\n",
      "  Saul-Wilkes-Stevenson: 1\n",
      "  Pegaptanib: 1\n",
      "  OTC: 1\n",
      "  Bailey-Bloch: 1\n",
      "  Tryptophanuria: 1\n",
      "  AICA-ribosiduria: 1\n",
      "  extrasystoles-short: 1\n",
      "  Tracheobronchomalacia: 1\n",
      "  hypercholanemia,: 1\n",
      "  telecanthus: 1\n",
      "  Schnitzler: 1\n",
      "  Genu: 1\n",
      "  Brachmann-de: 1\n",
      "  Fanconi-like: 1\n",
      "  ocular: 3\n",
      "  HSD10: 2\n",
      "  megacystis-microcolon-intestinal: 1\n",
      "  SCARF: 1\n",
      "  Cohen-Gibson: 1\n",
      "  Progesterone: 1\n",
      "  Morphological: 1\n",
      "  tyrosinemia: 1\n",
      "  eyebrow: 1\n",
      "  metachondromatosis: 1\n",
      "  dislocation: 1\n",
      "  fructose: 2\n",
      "  gaze: 1\n",
      "  Cognitive: 1\n",
      "  fenton: 1\n",
      "  TFRC-related: 1\n",
      "  oculocerebrorenal: 1\n",
      "  free: 2\n",
      "  neurocutaneous: 1\n",
      "  irritable: 1\n",
      "  velo-facial-skeletal: 1\n",
      "  Ioversol: 1\n",
      "  hypophosphatasia: 1\n",
      "  Wilson: 1\n",
      "  SOX4: 1\n",
      "  Mitral: 1\n",
      "  RPGR: 1\n",
      "  Sirolimus: 1\n",
      "  Muckle-Wells: 1\n",
      "  galactorrhea: 1\n",
      "  MLC1: 1\n",
      "  Lamivudine: 1\n",
      "  bradyopsia: 1\n",
      "  Winchester: 1\n",
      "  cryohydrocytosis: 1\n",
      "  Leri: 1\n",
      "  Laronidase: 1\n",
      "  HSD17B4: 1\n",
      "  Esatenolol: 1\n",
      "  Dubowitz: 1\n",
      "  Facial: 1\n",
      "  Cowden: 1\n",
      "  Naxos: 1\n",
      "  HYAL1: 1\n",
      "  myasthenia,: 1\n",
      "  cardiocranial: 1\n",
      "  hydrocephalus-costovertebral: 1\n",
      "  antenatal: 1\n",
      "  Gatifloxacin: 1\n",
      "  Koolen: 1\n",
      "  Clobetasone: 1\n",
      "  alobar: 1\n",
      "  hymen,: 1\n",
      "  Acebutolol: 1\n",
      "  Machado-Joseph: 1\n",
      "  Baraitser-Winter: 1\n",
      "  Letrozole: 1\n",
      "  Beardwell: 1\n",
      "  lamellar: 1\n",
      "  dermochondrocorneal: 1\n",
      "  Vici: 1\n",
      "  microcephaly-congenital: 1\n",
      "  Reis-Bucklers: 1\n",
      "  aceruloplasminemia: 1\n",
      "  SESN2: 1\n",
      "  necrotizing: 1\n",
      "  BRESEK: 1\n",
      "  Fryns: 3\n",
      "  achalasia: 2\n",
      "  cardiac,: 1\n",
      "  gluthathione: 1\n",
      "  Fosinopril: 1\n",
      "  adrenomyodystrophy: 1\n",
      "  Slti-Salem: 1\n",
      "  Lynch: 1\n",
      "  GUSB: 1\n",
      "  megalencephaly-polymicrogyria-polydactyly-hydrocephalus: 1\n",
      "  brachymesomelia-renal: 1\n",
      "  Grayish: 1\n",
      "  Gabapentin: 1\n",
      "  apert-like: 1\n",
      "  cataract-ataxia-deafness: 1\n",
      "  xylosidase: 1\n",
      "  orthostatic: 1\n",
      "  Creutzfeldt-Jakob: 1\n",
      "  PANK2: 1\n",
      "  SPATC1L: 1\n",
      "  Bonnemann-Meinecke-Reich: 1\n",
      "  Bicalutamide: 1\n",
      "  Brain: 1\n",
      "  Sandifer: 1\n",
      "  histidine: 1\n",
      "  ALG3-CDG: 1\n",
      "  diabetes: 3\n",
      "  Betaxolol: 1\n",
      "  microgastria-limb: 1\n",
      "  hydrolase: 1\n",
      "  Parnaparin: 1\n",
      "  hypoproteinemia,: 1\n",
      "  RPGRIP1L: 1\n",
      "  immunoglobulin: 1\n",
      "  neurodegeneration: 2\n",
      "  microcytic: 1\n",
      "  gluteal: 1\n",
      "  pseudoxanthoma: 1\n",
      "  Hyperactive: 1\n",
      "  Harrod: 1\n",
      "  OCLN: 1\n",
      "  stiff: 1\n",
      "  eye: 1\n",
      "  cutler: 1\n",
      "  Teriparatide: 1\n",
      "  MPI-CDG: 1\n",
      "  brachyolmia: 2\n",
      "  Megestrol: 1\n",
      "  IDS: 1\n",
      "  Frontal: 1\n",
      "  hypoglossia-hypodactyly: 1\n",
      "  Imerslund-Grasbeck: 1\n",
      "  2q37: 1\n",
      "  Proximal: 1\n",
      "  ERLIN2: 1\n",
      "  Nadroparin: 1\n",
      "  lymphedema-posterior: 1\n",
      "  Pallister-W: 1\n",
      "  antiphospholipid: 1\n",
      "  macrocephaly-intellectual: 1\n",
      "  Gadobenic: 1\n",
      "  limb-girdle: 2\n",
      "  otofacioosseous-gonadal: 1\n",
      "  Saethre-Chotzen: 1\n",
      "  hypothyroidism,: 1\n",
      "  Betamethasone: 1\n",
      "  Melatonin: 1\n",
      "  ALG1-CDG: 1\n",
      "  neural: 2\n",
      "  pelvic: 1\n",
      "  Crigler-Najjar: 1\n",
      "  scrub: 1\n",
      "  ichthyosiform: 1\n",
      "  hemochromatosis: 1\n",
      "  alpha-mannosidosis: 1\n",
      "  Clonidine: 1\n",
      "  hyper-IgE: 2\n",
      "  annular: 1\n",
      "  PHACE: 1\n",
      "  glutaryl-CoA: 1\n",
      "  Indomethacin: 1\n",
      "  Baclofen: 1\n",
      "  megalencephaly,: 1\n",
      "  3-M: 1\n",
      "  Clomifene: 1\n",
      "  MBOAT2: 1\n",
      "  Morquio: 1\n",
      "  Spinal: 1\n",
      "  Barber-Say: 1\n",
      "  Etacrynic: 1\n",
      "  20q13.33: 1\n",
      "  Fuqua: 1\n",
      "  Thalidomide: 1\n",
      "  Urinary: 1\n",
      "  Pitt-Hopkins-like: 1\n",
      "  Kindler: 1\n",
      "  NTF3: 1\n",
      "  Glanzmann: 1\n",
      "  CCDC50: 1\n",
      "  Cardiomyopathy: 1\n",
      "  mo: 1\n",
      "  Ayme-Gripp: 1\n",
      "  Blotching: 1\n",
      "  CD4: 1\n",
      "  pseudotumor: 1\n",
      "  FOXC1: 1\n",
      "  GRHL2: 1\n",
      "  MYH7-related: 1\n",
      "  dentinogenesis: 2\n",
      "  aortic: 3\n",
      "  rapid-onset: 1\n",
      "  brain-lung-thyroid: 1\n",
      "  warburg-cinotti: 1\n",
      "  BTD: 1\n",
      "  Pallister-hall: 1\n",
      "  cortisone: 1\n",
      "  oculo-cerebral: 1\n",
      "  Cupped: 1\n",
      "  triosephosphate: 1\n",
      "  microtriplication: 1\n",
      "  Eszopiclone: 1\n",
      "  Milrinone: 1\n",
      "  Boomerang: 1\n",
      "  NR1H2: 1\n",
      "  nail-patella: 1\n",
      "  Cefpodoxime: 1\n",
      "  KAT8: 1\n",
      "  piriformis: 1\n",
      "  Adams-Stokes: 1\n",
      "  Glimepiride: 1\n",
      "  Albright-like: 1\n",
      "  Revesz: 1\n",
      "  TGFB1: 1\n",
      "  phocomelia,: 1\n",
      "  Kanamycin: 1\n",
      "  hypo-: 1\n",
      "  Sheehan: 1\n",
      "  cyanosis: 1\n",
      "  steroid-responsive: 1\n",
      "  Hernández-Aguirre: 1\n",
      "  Charlie: 1\n",
      "  Sillence: 1\n",
      "  Rajab: 1\n",
      "  Superior: 1\n",
      "  obsessive-compulsive: 1\n",
      "  frontal: 1\n",
      "  CEDNIK: 1\n",
      "  leukoencephalopathy-dystonia-motor: 1\n",
      "  pediatric-onset: 1\n",
      "  Ammon's: 1\n",
      "  bidirectional: 1\n",
      "  stiff-person: 1\n",
      "  Vissers-Bodmer: 1\n",
      "  TLR4: 1\n",
      "  coxoauricular: 1\n",
      "  chylous: 1\n",
      "  Leber: 2\n",
      "  ventriculomegaly-cystic: 1\n",
      "  Lhermitte-Duclos: 1\n",
      "  berry: 1\n",
      "  CARASIL: 1\n",
      "  burning: 1\n",
      "  Alkuraya-Kucinskas: 1\n",
      "  Sildenafil: 1\n",
      "  Methohexital: 1\n",
      "  thymic-renal-anal-lung: 1\n",
      "  Rabson-Mendenhall: 1\n",
      "  hypervitaminosis: 1\n",
      "  AVP: 1\n",
      "  tetraamelia-multiple: 1\n",
      "  cytosolic: 1\n",
      "  Macroglossia: 1\n",
      "  craniosynostosis-hydrocephalus-Arnold-Chiari: 1\n",
      "  dermatocardioskeletal: 1\n",
      "  predisposition: 1\n",
      "  Dubin-Johnson: 1\n",
      "  Gliclazide: 1\n",
      "  CD44: 1\n",
      "  Delpire-McNeill: 1\n",
      "  Propylthiouracil: 1\n",
      "  Andersen-Tawil: 1\n",
      "  EJM1: 1\n",
      "  perioral: 1\n",
      "  acrocephalopolydactyly: 1\n",
      "  Prednisolone: 1\n",
      "  bronchial: 1\n",
      "  macrocephaly-autism: 1\n",
      "  keratosis: 2\n",
      "  FAS: 1\n",
      "  humeroradial: 2\n",
      "  Isradipine: 1\n",
      "  mycophenolate: 1\n",
      "  anemia: 1\n",
      "  quadriceps: 1\n",
      "  Thai: 1\n",
      "  holocarboxylase: 1\n",
      "  neuroferritinopathy: 1\n",
      "  Pearson: 1\n",
      "  Onychotrichodysplasia: 1\n",
      "  Degeneration: 1\n",
      "  NGLY1-deficiency: 1\n",
      "  myalgia-eosinophilia: 1\n",
      "  Spondyloepimetaphyseal: 1\n",
      "  Sumatriptan: 1\n",
      "  Fenoprofen: 1\n",
      "  ventricular: 2\n",
      "  polyneuropathy-intellectual: 1\n",
      "  opsoclonus-myoclonus: 1\n",
      "  Oxymetholone: 1\n",
      "  pulmonic: 2\n",
      "  Stromme: 1\n",
      "  Tioguanine: 1\n",
      "  Eletriptan: 1\n",
      "  Enalapril: 1\n",
      "  Medroxyprogesterone: 1\n",
      "  microcephaly-corpus: 1\n",
      "  Rahman: 1\n",
      "  Sandhaus-Ben-Ami: 1\n",
      "  neurofibromatosis-Noonan: 1\n",
      "  C: 1\n",
      "  Degarelix: 1\n",
      "  deaf: 1\n",
      "  hydrocephaly-tall: 1\n",
      "  Bowen-Conradi: 1\n",
      "  cat-eye: 1\n",
      "  Hypertrophic: 1\n",
      "  Desogestrel: 1\n",
      "  GABA: 1\n",
      "  cannabinoid: 1\n",
      "  Iopromide: 1\n",
      "  Amantadine: 1\n",
      "  cardiofaciocutaneous: 1\n",
      "  atrophoderma: 2\n",
      "  NEK9-related: 1\n",
      "  amastia,: 1\n",
      "  TGFA: 1\n",
      "  Griscelli: 1\n",
      "  alpha-thalassemia-abnormal: 1\n",
      "  aniridia-renal: 1\n",
      "  glossopalatine: 1\n",
      "  tarsal-carpal: 1\n",
      "  Flumazenil: 1\n",
      "  humerofemoral: 1\n",
      "  dilated: 2\n",
      "  3-hydroxyisobutyric: 1\n",
      "  Lopes-Maciel-Rodan: 1\n",
      "  CYGB: 1\n",
      "  gas: 1\n",
      "  Tropicamide: 1\n",
      "  Paresthesia: 1\n",
      "  Cockayne: 1\n",
      "  nonarteritic: 1\n",
      "  cocoon: 1\n",
      "  CREST: 1\n",
      "  ZTTK: 1\n",
      "  oxoglutaricaciduria: 1\n",
      "  COL11A2: 1\n",
      "  Carbamazepine: 1\n",
      "  achromatopsia: 1\n",
      "  RFT1-CDG: 1\n",
      "  Fluorouracil: 1\n",
      "  hypopigmentation,: 1\n",
      "  pancreatitis,: 1\n",
      "  HEC: 1\n",
      "  Nestor-Guillermo: 1\n",
      "  oculogastrointestinal: 1\n",
      "  Usher: 1\n",
      "  wormian: 1\n",
      "  cassavism: 1\n",
      "  Dermatan: 1\n",
      "  L-iduronidase: 1\n",
      "  legionellosis: 1\n",
      "  arthrogryposis-severe: 1\n",
      "  hyperbilirubinemia,: 2\n",
      "  neuroendocrine: 2\n",
      "  alkaline: 1\n",
      "  COG6-CGD: 1\n",
      "  ribbing: 1\n",
      "  reactive: 1\n",
      "  11p15.4: 1\n",
      "  diencephalic-mesencephalic: 1\n",
      "  T-cell: 1\n",
      "  PFAPA: 1\n",
      "  ulnar/fibula: 1\n",
      "  achondrogenesis: 1\n",
      "  hypoinsulinemic: 1\n",
      "  atrophia: 1\n",
      "  leukocyte: 1\n",
      "  tardive: 1\n",
      "  SIX1: 1\n",
      "  Pelizaeus-Merzbacher: 2\n",
      "  uterine: 1\n",
      "  distichiasis: 1\n",
      "  FG: 1\n",
      "  DNA: 1\n",
      "  hyperekplexia: 1\n",
      "  Diethylpropion: 1\n",
      "  Lowry-Wood: 1\n",
      "  Barre-Lieou: 1\n",
      "  biotinidase: 1\n",
      "  alveolar: 1\n",
      "  toes,: 1\n",
      "  Alfuzosin: 1\n",
      "  Lamotrigine: 1\n",
      "  Armfield: 1\n",
      "  magnesium,: 1\n",
      "  Weaver: 1\n",
      "  cramps,: 1\n",
      "  Trimethadione: 1\n",
      "  RIN2: 1\n",
      "  Scaphocephaly: 1\n",
      "  Valinemia: 1\n",
      "  RARS1: 1\n",
      "  oligomeganephronia: 1\n",
      "  cerebellum: 1\n",
      "  polysyndactyly-cardiac: 1\n",
      "  intestine: 1\n",
      "  APC: 1\n",
      "  acrogeria: 1\n",
      "  Trazodone: 1\n",
      "  curry-Jones: 1\n",
      "  alpha-thalassemia-myelodysplastic: 1\n",
      "  Leydig: 1\n",
      "  hyperlipoproteinemia: 1\n",
      "  Maxillary: 1\n",
      "  Scleral: 1\n",
      "  Berardinelli-Seip: 1\n",
      "  hypomagnesemia,: 1\n",
      "  Dysostosis: 1\n",
      "  Vocal: 1\n",
      "  Muscle: 2\n",
      "  Profound: 2\n",
      "  green: 1\n",
      "  Pituitary: 1\n",
      "  neurooculocardiogenitourinary: 1\n",
      "  genito-palato-cardiac: 1\n",
      "  ketoacidosis: 1\n",
      "  Camptosynpolydactyly,: 1\n",
      "  thrombocytopenia: 1\n",
      "  otofaciocervical: 1\n",
      "  Candesartan: 1\n",
      "  post-infectious: 1\n",
      "  Azelastine: 1\n",
      "  fibrosis: 1\n",
      "  malaria: 1\n",
      "  CS/DS: 1\n",
      "  ADORA1: 1\n",
      "  Parana: 1\n",
      "  urban-Rogers-Meyer: 1\n",
      "  Pes: 1\n",
      "  polyneuropathy-hand: 1\n",
      "  SLC1A1: 1\n",
      "  IL21-related: 1\n",
      "  Hypotonia: 1\n",
      "  Papillon-Lefevre: 1\n",
      "  early: 1\n",
      "  Ovoid: 1\n",
      "  ulnar: 1\n",
      "  auricular: 1\n",
      "  Cohen: 2\n",
      "  Sulfadiazine: 1\n",
      "  RELA: 1\n",
      "  testes,: 1\n",
      "  Scheuermann: 1\n",
      "  solitary: 1\n",
      "  nephropathic: 1\n",
      "  biotin-responsive: 1\n",
      "  EIF4A3: 1\n",
      "  Ramon: 1\n",
      "  Juberg-Hayward: 1\n",
      "  septooptic: 1\n",
      "  NR1H4: 1\n",
      "  15q11q13: 1\n",
      "  triple-A: 1\n",
      "  Palonosetron: 1\n",
      "  Cubitus: 2\n",
      "  tempi: 1\n",
      "  Epirubicin: 1\n",
      "  Bortezomib: 1\n",
      "  Wildervanck: 1\n",
      "  Busulfan: 1\n",
      "  Donohue: 1\n",
      "  Salsalate: 1\n",
      "  TMPRSS3: 1\n",
      "  Doxorubicin: 1\n",
      "  arthrogryposis-like: 2\n",
      "  FGF7: 1\n",
      "  malonic: 1\n",
      "  hypervalinemia: 1\n",
      "  2/L-2-hydroxyglutaric: 1\n",
      "  hyperinsulinemic: 1\n",
      "  Valganciclovir: 1\n",
      "  sarcoidosis,: 1\n",
      "  cardiac-urogenital: 1\n",
      "  polymyositis: 1\n",
      "  Coat: 1\n",
      "  16p11.2p12.2: 1\n",
      "  O'Donnell-Luria-Rodan: 1\n",
      "  duodenum: 1\n",
      "  myalgic: 1\n",
      "  hypersecretion: 1\n",
      "  fibula: 1\n",
      "  exostoses,: 1\n",
      "  Dextrothyroxine: 1\n",
      "  terminal: 1\n",
      "  MAPK3: 1\n",
      "  SLC5A6: 1\n",
      "  isotretinoin: 1\n",
      "  Deferasirox: 1\n",
      "  aglossia: 1\n",
      "  acetyl-CoA: 1\n",
      "  myoglobinuria,: 1\n",
      "  Celecoxib: 1\n",
      "  AHI1: 1\n",
      "  typhoid: 1\n",
      "  Wilson-Turner: 1\n",
      "  Reduced: 2\n",
      "  anotia: 1\n",
      "  hypotonia-speech: 1\n",
      "  nephronophthisis-like: 1\n",
      "  Bruton-type: 1\n",
      "  faciocardiomelic: 1\n",
      "  endometrium: 1\n",
      "  prostate: 1\n",
      "  dorsolateral: 1\n",
      "  Gorham-Stout: 1\n",
      "  megalencephaly-polymicrogyria-postaxial: 1\n",
      "  Prepapillary: 1\n",
      "  language: 1\n",
      "  dyssegmental: 2\n",
      "  dysmyelination: 1\n",
      "  Valsartan: 1\n",
      "  CLAPO: 1\n",
      "  brachyolmia-amelogenesis: 1\n",
      "  alternating: 1\n",
      "  triokinase: 1\n",
      "  palatal: 1\n",
      "  Graham-Boyle-Troxell: 1\n",
      "  Zuclopenthixol: 1\n",
      "  gracile: 1\n",
      "  KEAP1: 1\n",
      "  Quinine: 1\n",
      "  Fluconazole: 1\n",
      "  Aliskiren: 1\n",
      "  chikungunya: 1\n",
      "  aminoacylase: 1\n",
      "  Hhhh: 1\n",
      "  weinstein: 1\n",
      "  microbrachycephaly-ptosis-cleft: 1\n",
      "  keratoderma: 1\n",
      "  Alice: 1\n",
      "  Dihydroergotamine: 1\n",
      "  Beemer-Ertbruggen: 1\n",
      "  KBG: 1\n",
      "  Johanson-Blizzard: 1\n",
      "  ataxia-hypogonadism-choroidal: 1\n",
      "  bifid: 2\n",
      "  Bracket: 1\n",
      "  ACTH-independent: 1\n",
      "  Risedronic: 1\n",
      "  Newfoundland: 1\n",
      "  hyperpigmentation: 1\n",
      "  Alzheimer: 1\n",
      "  ABri: 1\n",
      "  Sibutramine: 1\n",
      "  cerebrofaciothoracic: 1\n",
      "  testis: 1\n",
      "  1q44: 1\n",
      "  postpoliomyelitis: 1\n",
      "  megalocornea: 1\n",
      "  convulsive: 1\n",
      "  Communicating: 1\n",
      "  laryngotracheoesophageal: 1\n",
      "  Suleiman-El-Hattab: 1\n",
      "  pseudo-TORCH: 1\n",
      "  action: 1\n",
      "  cone: 2\n",
      "  Central: 2\n",
      "  BDKRB1: 1\n",
      "  A1BG: 1\n",
      "  CAMK2A: 1\n",
      "  Terazosin: 1\n",
      "  Sinusitis: 1\n",
      "  megaconial: 1\n",
      "  atherosclerosis-deafness-diabetes-epilepsy-nephropathy: 1\n",
      "  Fowler: 1\n",
      "  Right: 1\n",
      "  Nathalie: 1\n",
      "  Ulbright-Hodes: 1\n",
      "  Carpenter: 1\n",
      "  Acetylsalicylic: 1\n",
      "  Kandori: 1\n",
      "  Chlorhexidine: 1\n",
      "  acrocraniofacial: 1\n",
      "  Fentanyl: 1\n",
      "  polymyoclonus,: 1\n",
      "  GM1: 1\n",
      "  15q14: 1\n",
      "  hypertrichotic: 1\n",
      "  Exemestane: 1\n",
      "  Intimal: 1\n",
      "  adducted: 1\n",
      "  Amphetamine: 1\n",
      "  Ellis-van: 1\n",
      "  granddad: 1\n",
      "  Pectus: 1\n",
      "  Laurence-Moon: 1\n",
      "  Perry: 1\n",
      "  ichthyosis,: 1\n",
      "  Diatrizoate: 1\n",
      "  SC: 1\n",
      "  Kashani-Strom-Utley: 1\n",
      "  Buspirone: 1\n",
      "  lipase: 1\n",
      "  pseudoachondroplasia: 1\n",
      "  neurodevelopmental,: 1\n",
      "  Docetaxel: 1\n",
      "  Laugier-Hunziker: 1\n",
      "  holoprosencephaly-hypokinesia-congenital: 1\n",
      "  STING-associated: 1\n",
      "  photomyoclonus,: 1\n",
      "  vermiform: 1\n",
      "  hyperphosphatasia-intellectual: 1\n",
      "  cirrhosis,: 1\n",
      "  ankle: 1\n",
      "  12q14: 1\n",
      "  genitopatellar: 1\n",
      "  dystonia,: 1\n",
      "  fibrogenesis: 1\n",
      "  Atovaquone: 1\n",
      "  Glipizide: 1\n",
      "  ACOT1: 1\n",
      "  glossopharyngeal: 1\n",
      "  allergic: 1\n",
      "  Threoninemia: 1\n",
      "  listeriosis: 1\n",
      "  agammaglobulinemia-microcephaly-craniosynostosis-severe: 1\n",
      "  FOXI1: 1\n",
      "  osteoma: 1\n",
      "  cochleosaccular: 1\n",
      "  Biemond: 1\n",
      "  hypertelorism-preauricular: 1\n",
      "  tubulointerstitial: 1\n",
      "  temporomandibular: 1\n",
      "  split-foot: 1\n",
      "  SLC26A2: 1\n",
      "  Rosuvastatin: 1\n",
      "  Sandhoff: 1\n",
      "  Lambert: 1\n",
      "  Rasburicase: 1\n",
      "  enchondromatosis: 1\n",
      "  choroideremia-deafness-obesity: 1\n",
      "  Bumetanide: 1\n",
      "  Lenz-Majewski: 1\n",
      "  PARP1: 1\n",
      "  Periorbital: 1\n",
      "  Ullrich: 1\n",
      "  uncombable: 1\n",
      "  CYBA: 1\n",
      "  PCNA-related: 1\n",
      "  Wiedemann-Steiner: 1\n",
      "  fascial: 1\n",
      "  melorheostosis: 1\n",
      "  aniridia-cerebellar: 1\n",
      "  monilethrix: 1\n",
      "  trismus-pseudocamptodactyly: 1\n",
      "  SGSH: 1\n",
      "  McKusick-Kaufman: 1\n",
      "  SLC18A2: 1\n",
      "  narcolepsy-cataplexy: 1\n",
      "  material: 1\n",
      "  genetic: 1\n",
      "  facio: 2\n",
      "  D,L-2-hydroxyglutaric: 1\n",
      "  arteriosclerosis,: 1\n",
      "  hypercalcemia,: 1\n",
      "  methylmalonate: 1\n",
      "  Freiberg: 1\n",
      "  SNCA: 1\n",
      "  Mitoxantrone: 1\n",
      "  Scott: 1\n",
      "  FGF2: 1\n",
      "  MAPK1: 1\n",
      "  tremor,: 1\n",
      "  Anteverted: 1\n",
      "  choreoacanthocytosis: 1\n",
      "  OTOA: 1\n",
      "  Escitalopram: 1\n",
      "  nevus: 1\n",
      "  erythrokeratoderma: 1\n",
      "  EAST: 1\n",
      "  tiglic: 1\n",
      "  RALGAPA1: 1\n",
      "  protein-losing: 1\n",
      "  syndactyly-telecanthus-anogenital: 1\n",
      "  Jervell: 1\n",
      "  POMC: 1\n",
      "  short-rib: 1\n",
      "  Amitriptyline: 1\n",
      "  parastremmatic: 1\n",
      "  2q33.1: 1\n",
      "  Irinotecan: 1\n",
      "  Krieble: 1\n",
      "  dentin: 1\n",
      "  Alitretinoin: 1\n",
      "  pancreatitis: 1\n",
      "  16p12.1p12.3: 1\n",
      "  maturity-onset: 1\n",
      "  Addison: 1\n",
      "  Disinhibition: 1\n",
      "  PRKN: 1\n",
      "  MMEP: 1\n",
      "  3MC: 1\n",
      "  Tiaprofenic: 1\n",
      "  Moclobemide: 1\n",
      "  ruvalcaba: 1\n",
      "  Leri-Weill: 1\n",
      "  Streptokinase: 1\n",
      "  Duker-Weiss-Siber: 1\n",
      "  Sheldon-hall: 1\n",
      "  cherubism: 1\n",
      "  Rofecoxib: 1\n",
      "  locked-in: 1\n",
      "  osteoglophonic: 1\n",
      "  High-frequency: 1\n",
      "  Idursulfase: 1\n",
      "  carbon: 1\n",
      "  hypertrichosis-acromegaloid: 1\n",
      "  Cronkhite-Canada: 1\n",
      "  Maraviroc: 1\n",
      "  COG4-CDG: 1\n",
      "  Micafungin: 1\n",
      "  otodental: 1\n",
      "  aprosencephaly: 1\n",
      "  hyperbiliverdinemia: 1\n",
      "  neuralgic: 1\n",
      "  nephropathy: 1\n",
      "  Methadone: 1\n",
      "  16p13.2: 1\n",
      "  anauxetic: 1\n",
      "  Elosulfase: 1\n",
      "  SRD5A3-CDG: 1\n",
      "  GALNT13: 1\n",
      "  Lower: 1\n",
      "  histiocytoid: 1\n",
      "  chondroitin-6-sulfaturia,: 1\n",
      "  Infantile: 1\n",
      "  Tacrolimus: 1\n",
      "  aganglionosis,: 1\n",
      "  PPP1R21: 1\n",
      "  Doxazosin: 1\n",
      "  ZMAT3: 1\n",
      "  STAT5B: 1\n",
      "  dermatan: 1\n",
      "  Scheie: 1\n",
      "  Kufor-Rakeb: 1\n",
      "  TECPR2: 1\n",
      "  Sulindac: 1\n",
      "  Ketoadipicaciduria: 1\n",
      "  Sneddon: 1\n",
      "  brachycephaly,: 1\n",
      "  oocyte: 1\n",
      "  insomnia: 1\n",
      "  Glycerin: 1\n",
      "  rubinstein: 1\n",
      "  TRAPPC4: 1\n",
      "  16p13.11: 2\n",
      "  Pseudoepiphyses: 1\n",
      "  porencephaly: 1\n",
      "  freeman-Sheldon: 1\n",
      "  F2: 1\n",
      "  alpha-N-acetylgalactosaminidase: 1\n",
      "  PINK1: 1\n",
      "  tick-borne: 1\n",
      "  Latanoprost: 1\n",
      "  Bemiparin: 1\n",
      "  2p21: 1\n",
      "  craniosynostosis-Dandy-Walker: 1\n",
      "  urocanic: 1\n",
      "  placenta: 1\n",
      "  Alprazolam: 1\n",
      "  progesterone: 1\n",
      "  taurodontism: 1\n",
      "  breasts: 1\n",
      "  AKT2-related: 1\n",
      "  Kleine-Levin: 1\n",
      "  segmental: 1\n",
      "  SLC1A2: 1\n",
      "  fructose-1,6-bisphosphatase: 1\n",
      "  widow's: 1\n",
      "  microsporidiosis: 1\n",
      "  ichthyosis-alopecia-eclabion-ectropion-intellectual: 1\n",
      "  pachydermoperiostosis: 1\n",
      "  Lyell: 1\n",
      "  hypoparathyroidism-retardation-dysmorphism: 1\n",
      "  Corticotropin: 1\n",
      "  USH2A: 1\n",
      "  acanthosis: 1\n",
      "  keratoconus: 1\n",
      "  Arrhythmia: 1\n",
      "  KCNJ6: 1\n",
      "  Silverman-Handmaker: 1\n",
      "  Samson-Gardner: 1\n",
      "  MYO1A: 1\n",
      "  bruxism: 1\n",
      "  polydactyly: 1\n",
      "  camptodactyly,: 1\n",
      "  Evans: 1\n",
      "  mirror: 2\n",
      "  Dias-Logan: 1\n",
      "  Krauss: 1\n",
      "  Seizure: 1\n",
      "  Deformed: 1\n",
      "  argininosuccinic: 1\n",
      "  Cardioneuromyopathy: 1\n",
      "  Hyoscyamine: 1\n",
      "  Porfimer: 1\n",
      "  Spondylometaphyseal: 1\n",
      "  Tietz: 1\n",
      "  brachymetapody: 1\n",
      "  Chaddock: 1\n",
      "  poikiloderma: 1\n",
      "  Kabuki: 1\n",
      "  APLP2: 1\n",
      "  epilepsy-telangiectasia: 1\n",
      "  cold-induced: 1\n",
      "  temporal: 1\n",
      "  Captopril: 1\n",
      "  Cyclosporine: 1\n",
      "  SSR4-CDG: 1\n",
      "  euthyroid: 1\n",
      "  Tiludronic: 1\n",
      "  succinic: 2\n",
      "  Indapamide: 1\n",
      "  CNR1: 1\n",
      "  Aminoglycoside-induced: 1\n",
      "  hydranencephaly: 1\n",
      "  extraoral: 1\n",
      "  papillary: 1\n",
      "  Ofloxacin: 1\n",
      "  left: 1\n",
      "  Dextropropoxyphene: 1\n",
      "  periodontitis,: 2\n",
      "  trichohepatoenteric: 1\n",
      "  Marfan: 1\n",
      "  LOXHD1: 1\n",
      "  ankyloblepharon-ectodermal: 1\n",
      "  glutamate: 1\n",
      "  musk,: 1\n",
      "  Kearns-Sayre: 1\n",
      "  XDH: 1\n",
      "  coccidioidomycosis: 1\n",
      "  GTP: 1\n",
      "  cryptosporidiosis: 1\n",
      "  friedreich: 1\n",
      "  Sifrim-Hitz-Weiss: 1\n",
      "  hepatocellular: 1\n",
      "  desquamative: 1\n",
      "  Refsum: 1\n",
      "  microcephaly-cerebellar: 1\n",
      "  hyperprolinemia: 1\n",
      "  Erdheim-Chester: 1\n",
      "  cholestasis,: 1\n",
      "  alacrima,: 2\n",
      "  Amsacrine: 1\n",
      "  FRAXF: 1\n",
      "  MYO3A: 1\n",
      "  gamma-glutamyl: 1\n",
      "  Stiripentol: 1\n",
      "  CISD2: 1\n",
      "  oculocerebrofacial: 1\n",
      "  eosinophil: 1\n",
      "  Loeys-Dietz: 1\n",
      "  Teebi-Shaltout: 1\n",
      "  Maffucci: 1\n",
      "  cerebrocostomandibular: 1\n",
      "  acroosteolysis: 1\n",
      "  ophthalmoplegic: 1\n",
      "  hyperkalemic: 1\n",
      "  EPO: 1\n",
      "  diastematomyelia: 1\n",
      "  Ververi-Brady: 1\n",
      "  BAX: 1\n",
      "  parkinsonian-pyramidal: 1\n",
      "  Ascites: 1\n",
      "  Zoledronic: 1\n",
      "  aniridia-absent: 1\n",
      "  frontorhiny: 1\n",
      "  Relative: 1\n",
      "  disorder: 2\n",
      "  Estradiol: 1\n",
      "  Hodgkins: 1\n",
      "  Modic: 1\n",
      "  Danazol: 1\n",
      "  Lenalidomide: 1\n",
      "  embryonal: 1\n",
      "  Schwartz-Jampel: 1\n",
      "  CABCOCO1: 1\n",
      "  citrullinemia,: 1\n",
      "  sclerosing: 1\n",
      "  Pimozide: 1\n",
      "  endocrine-cerebro-osteodysplasia: 1\n",
      "  Tizanidine: 1\n",
      "  aniridia-ptosis-intellectual: 1\n",
      "  achondroplasia: 1\n",
      "  trigonocephaly: 1\n",
      "  ataxia-microcephaly-cataract: 1\n",
      "  MORM: 1\n",
      "  MEHMO: 1\n",
      "  Reese: 1\n",
      "  14q12: 1\n",
      "  young: 1\n",
      "  49,XXXYY: 1\n",
      "  Elsahy-Waters: 1\n",
      "  localized: 1\n",
      "  myeloproliferative: 1\n",
      "  deeah: 1\n",
      "  Christianson: 1\n",
      "  richieri-costa: 1\n",
      "  Hydroxychloroquine: 1\n",
      "  Juvenile: 1\n",
      "  Farber: 1\n",
      "  Riluzole: 1\n",
      "  Methotrexate: 1\n",
      "  meningioma: 1\n",
      "  Stippled: 1\n",
      "  Clopenthixol: 1\n",
      "  Methylprednisolone: 1\n",
      "  Zellweger-like: 1\n",
      "  Amobarbital,: 1\n",
      "  retinopathy,: 1\n",
      "  Ulnar: 1\n",
      "  Arts: 1\n",
      "  symphalangism,: 1\n",
      "  ERCC6: 1\n",
      "  paraplegia-intellectual: 1\n",
      "  Beare-Stevenson: 1\n",
      "  Loteprednol: 1\n",
      "  peroxisome: 1\n",
      "  talo-patello-scaphoid: 1\n",
      "  hyperdibasic: 1\n",
      "  cholesterol: 1\n",
      "  Gadodiamide: 1\n",
      "  45,X/46,XY: 1\n",
      "  ectrodactyly: 2\n",
      "  Catifa: 1\n",
      "  Holt-Oram: 1\n",
      "  22q11.2: 1\n",
      "  hypotrichosis-lymphedema-telangiectasia-renal: 1\n",
      "  brachydactylous: 1\n",
      "  KID: 1\n",
      "  granulocytopenia: 1\n",
      "  reticulum: 1\n",
      "  7q11.23: 1\n",
      "  dystrophy: 1\n",
      "  schizophrenia: 1\n",
      "  Peyronie: 1\n",
      "  spondyloarthropathy,: 1\n",
      "  Ataxia: 1\n",
      "  Kayser-Fleischer: 1\n",
      "  normophosphatemic: 1\n",
      "  Lowry-MacLean: 1\n",
      "  SMAD4: 1\n",
      "  vitiligo: 1\n",
      "  deafness-vitiligo-achalasia: 1\n",
      "  Bromfenac: 1\n",
      "  Acetazolamide: 1\n",
      "  POLD1: 1\n",
      "  Eprosartan: 1\n",
      "  GRM4: 1\n",
      "  ANE: 1\n",
      "  HDC: 1\n",
      "  campomelia,: 1\n",
      "  3p25.3: 1\n",
      "  dysautonomia-like: 1\n",
      "  cytochrome-c: 1\n",
      "  striatonigral: 1\n",
      "  Ibuprofen: 1\n",
      "  Allopurinol: 1\n",
      "  Dexibuprofen: 1\n",
      "  CP: 1\n",
      "  Grubben-de: 1\n",
      "  citrullinemia: 1\n",
      "  grouped: 1\n",
      "  vertebral,: 1\n",
      "  Immunoerythromyeloid: 1\n",
      "  elliptocytosis: 1\n",
      "  amygdala: 1\n",
      "  CRYGD: 1\n",
      "  Marden-Walker: 1\n",
      "  Butorphanol: 1\n",
      "  Ziprasidone: 1\n",
      "  Colestipol: 1\n",
      "  gnb5-related: 1\n",
      "  Stern-Lubinsky-Durrie: 1\n",
      "  apnea,: 1\n",
      "  Landy-Donnai: 1\n",
      "  Cortes: 1\n",
      "  20q11.2: 2\n",
      "  Paliperidone: 1\n",
      "  Allan-Herndon-Dudley: 1\n",
      "  STT3A-CDG: 1\n",
      "  Flynn-Aird: 1\n",
      "  duplication/inversion: 1\n",
      "  Matthew-Wood: 1\n",
      "  Capecitabine: 1\n",
      "  caecum: 1\n",
      "  ulnar-mammary: 1\n",
      "  CD9: 1\n",
      "  membranoproliferative: 1\n",
      "  rapadilino: 1\n",
      "  brachytelephalangy-dysmorphism-Kallmann: 1\n",
      "  Buprenorphine: 1\n",
      "  sterile: 1\n",
      "  verrucous: 1\n",
      "  hepatoencephalopathy: 1\n",
      "  Leriche: 1\n",
      "  Ranitidine: 1\n",
      "  middle: 1\n",
      "  apolipoprotein: 1\n",
      "  colon: 2\n",
      "  athyreosis: 1\n",
      "  Perindopril: 1\n",
      "  Paclitaxel: 1\n",
      "  flat: 1\n",
      "  nebulin-related: 1\n",
      "  Intrauterine: 1\n",
      "  forsythe-wakeling: 1\n",
      "  vitiligo,: 1\n",
      "  Khan-Khan-Katsanis: 1\n",
      "  Saal-Bulas: 1\n",
      "  osteochondritis: 1\n",
      "  GRFoma: 1\n",
      "  Alprostadil: 1\n",
      "  Nitroglycerin: 1\n",
      "  Kostmann: 1\n",
      "  leukoencephalopathy-ataxia-hypodontia-hypomyelination: 1\n",
      "  gastroschisis: 1\n",
      "  mucopolysaccharidoses,: 1\n",
      "  Haddad: 1\n",
      "  Procarbazine: 1\n",
      "  ABetaL34V: 1\n",
      "  encephalopathy-hypertrophic: 1\n",
      "  Navajo: 1\n",
      "  myopia: 1\n",
      "  Fluphenazine: 1\n",
      "  Pramipexole: 1\n",
      "  Pemetrexed: 1\n",
      "  German: 1\n",
      "  pseudohypoaldosteronism: 1\n",
      "  Raloxifene: 1\n",
      "  DPM3-CDG: 1\n",
      "  Arthralgia: 1\n",
      "  AREDYLD: 1\n",
      "  Ollier: 1\n",
      "  methimazole: 1\n",
      "  scurvy: 1\n",
      "  craniorhiny: 1\n",
      "  Flat: 1\n",
      "  microcephaly-deafness-intellectual: 1\n",
      "  Rasagiline: 1\n",
      "  Voriconazole: 1\n",
      "  gigantism: 1\n",
      "  Achard: 1\n",
      "  Mannitol: 1\n",
      "  Hydrocephalus: 1\n",
      "  tarsal: 1\n",
      "  ADRA1B: 1\n",
      "  PPP2CA: 1\n",
      "  Thomas: 1\n",
      "  desmoid: 1\n",
      "  secondary: 1\n",
      "  Xp22.13p22.2: 1\n",
      "  Zimmermann-Laband: 1\n",
      "  auditory: 1\n",
      "  campomelic: 1\n",
      "  Chagas: 1\n",
      "  ptosis-upper: 1\n",
      "  Fluvastatin: 1\n",
      "  Thakker-Donnai: 1\n",
      "  6q: 1\n",
      "  PTPN5: 1\n",
      "  nail-patella-like: 1\n",
      "  Tinzaparin: 1\n",
      "  Liddle: 1\n",
      "  Reynolds: 1\n",
      "  Prazosin: 1\n",
      "  cerebellar-facial-dental: 1\n",
      "  macrocephaly-spastic: 1\n",
      "  enhanced: 1\n",
      "  Hoarse: 1\n",
      "  ehlers-danlos: 2\n",
      "  Reboxetine: 1\n",
      "  Hepatomegaly: 1\n",
      "  leprosy: 1\n",
      "  undetermined: 1\n",
      "  Meester-Loeys: 1\n",
      "  Salmeterol: 1\n",
      "  Metyrapone: 1\n",
      "  hypercarotenemia: 1\n",
      "  Montelukast: 1\n",
      "  FCSK: 1\n",
      "  genitourinary: 1\n",
      "  Gentamicin: 1\n",
      "  cerebrooculonasal: 1\n",
      "  atlanto-axial: 1\n",
      "  Cetirizine: 1\n",
      "  Uruguay: 1\n",
      "  laurin-Sandrow: 1\n",
      "  ophthalmoplegia-intellectual: 1\n",
      "  Adams-Oliver: 1\n",
      "  centronuclear: 1\n",
      "  H: 1\n",
      "  Epinastine: 1\n",
      "  Sclerotic: 1\n",
      "  ALB: 1\n",
      "  Bazex-Dupre-Christol: 1\n",
      "  deafness-craniofacial: 1\n",
      "  Okamoto: 1\n",
      "  branchiootic: 1\n",
      "  Balsalazide: 1\n",
      "  hyperphenylalaninemia: 1\n",
      "  cataract-aberrant: 1\n",
      "  Methylphenidate: 1\n",
      "  Felty: 1\n",
      "  hydatidiform: 1\n",
      "  3-hydroxyisobutyryl-CoA: 1\n",
      "  Bilateral: 2\n",
      "  Diets-Jongmans: 1\n",
      "  Harel-Yoon: 1\n",
      "  19p13.3: 1\n",
      "  Isotretinoin: 1\n",
      "  islet: 1\n",
      "  Guillain-Barre: 1\n",
      "  Q: 1\n",
      "  acro-renal-mandibular: 1\n",
      "  alar: 1\n",
      "  Gemfibrozil: 1\n",
      "  pericardial: 1\n",
      "  Isoprenaline: 1\n",
      "  Pseudouridinuria: 1\n",
      "  MSRB3: 1\n",
      "  hypoglycemia,: 1\n",
      "  palindromic: 1\n",
      "  CLCN4-related: 1\n",
      "  MAN1B1-CDG: 1\n",
      "  DPAGT1-CDG: 1\n",
      "  beta-aminoisobutyric: 1\n",
      "  Desbuquois: 1\n",
      "  cholestasis: 1\n",
      "  Dinoprostone: 1\n",
      "  pseudomyxoma: 1\n",
      "  blepharophimosis-ptosis-esotropia-syndactyly-short: 1\n",
      "  Schuurs-Hoeijmakers: 1\n",
      "  CX3CR1: 1\n",
      "  Neu-Laxova: 1\n",
      "  ataxia-tapetoretinal: 1\n",
      "  Azacitidine: 1\n",
      "  lipoic: 1\n",
      "  Flattened: 1\n",
      "  Visual: 1\n",
      "  Hunter-Macdonald: 1\n",
      "  exfoliation: 1\n",
      "  hydrops-lactic: 1\n",
      "  fibromatosis: 1\n",
      "  iminoglycinuria: 1\n",
      "  Felodipine: 1\n",
      "  Dalteparin: 1\n",
      "  galactose: 1\n",
      "  deltoid: 1\n",
      "  Transient: 1\n",
      "  Grant: 1\n",
      "  calciphylaxis: 1\n",
      "  COG5-CDG: 1\n",
      "  Mazabraud: 1\n",
      "  cataract-growth: 1\n",
      "  Whipple: 1\n",
      "  neoplastic: 1\n",
      "  Nifedipine: 1\n",
      "  Sjogren: 1\n",
      "  Synophrys: 1\n",
      "  Venlafaxine: 1\n",
      "  cardiospondylocarpofacial: 1\n",
      "  mandibulofacial: 2\n",
      "  Retinitis: 1\n",
      "  Pitt-Hopkins: 1\n",
      "  Irregularity: 1\n",
      "  trichorhinophalangeal: 1\n",
      "  diomedi: 1\n",
      "  Spastic: 1\n",
      "  lymphoblastic: 1\n",
      "  right: 1\n",
      "  Al-Gazali: 1\n",
      "  Jaw: 1\n",
      "  Schaap-Taylor-Baraitser: 1\n",
      "  squamous: 1\n",
      "  7p22.1: 1\n",
      "  Schimke: 1\n",
      "  Memantine: 1\n",
      "  Braddock: 1\n",
      "  Fludrocortisone: 1\n",
      "  lymphangioleiomyomatosis: 1\n",
      "  tune: 1\n",
      "  Sanfilippo: 1\n",
      "  Vancomycin: 1\n",
      "  alcohol: 1\n",
      "  Losartan: 1\n",
      "  ALDH18A1-related: 1\n",
      "  Fenofibrate: 1\n",
      "  Shprintzen-Goldberg: 1\n",
      "  restless: 1\n",
      "  cerebrocortical: 1\n",
      "  EPOR: 1\n",
      "  glioma: 1\n",
      "  nonsyndromic: 1\n",
      "  GNS: 1\n",
      "  AGTPBP1: 1\n",
      "  Stereotypy: 1\n",
      "  Norman-Roberts: 1\n",
      "  ophthalmoplegia: 1\n",
      "  polymyalgia: 1\n",
      "  moyamoya: 1\n",
      "  Nisoldipine: 1\n",
      "  Behcet: 1\n",
      "  craniosynostosis-intracranial: 1\n",
      "  dehydratase: 1\n",
      "  Pesticides: 1\n",
      "  Procainamide: 1\n",
      "  Piroxicam: 1\n",
      "  Risperidone: 1\n",
      "  Flurbiprofen: 1\n",
      "  microcephaly-thin: 1\n",
      "  mitral: 1\n",
      "  teeth,: 1\n",
      "  mulibrey: 1\n",
      "  Dysplasia: 1\n",
      "  Rowley-Rosenberg: 1\n",
      "  postorgasmic: 1\n",
      "  pentosuria: 1\n",
      "  holoprosencephaly-radial: 1\n",
      "  Phentolamine: 1\n",
      "  frints: 1\n",
      "  Frank-Ter: 1\n",
      "  ABCD1: 1\n",
      "  gamma-glutamylcysteine: 1\n",
      "  otosclerosis: 1\n",
      "  Polyestradiol: 1\n",
      "  tuberous: 1\n",
      "  HBB: 1\n",
      "  Hepatosplenomegaly: 1\n",
      "  mucolipidosis: 2\n",
      "  deficiency: 1\n",
      "  glycosaminoglycan: 1\n",
      "  Deferiprone: 1\n",
      "  sleep: 1\n",
      "  NUDT2: 1\n",
      "  CODAS: 1\n",
      "  Hartnup: 1\n",
      "  hemangiomatosis,: 1\n",
      "  dystrophic: 1\n",
      "  diarrheal: 1\n",
      "  Everted: 1\n",
      "  Metoprolol: 1\n",
      "  Testosterone: 1\n",
      "  Niacin: 1\n",
      "  pseudoleprechaunism: 1\n",
      "  pyridoxine-responsive: 1\n",
      "  cryptococcosis: 1\n",
      "  grange: 1\n",
      "  Histiocytoid: 1\n",
      "  Sener: 1\n",
      "  Nicorandil: 1\n",
      "  Charles: 1\n",
      "  Chudley-McCullough: 1\n",
      "  Clofazimine: 1\n",
      "  Mallory-Weiss: 1\n",
      "  Waardenburg-Shah: 1\n",
      "  tricho-oculo-dermo-vertebral: 1\n",
      "  neurologic: 1\n",
      "  PMP22-RAI1: 1\n",
      "  epidermal: 2\n",
      "  Treprostinil: 1\n",
      "  dysmorphism-short: 1\n",
      "  OGG1: 1\n",
      "  joint: 1\n",
      "  ABHD5: 1\n",
      "  Muenke: 1\n",
      "  Anomalous: 1\n",
      "  urofacial: 1\n",
      "  daentl: 1\n",
      "  UV-sensitive: 1\n",
      "  Entrapment: 1\n",
      "  immunoskeletal: 1\n",
      "  Singleton-Merten: 1\n",
      "  GRN: 1\n",
      "  antithrombin,: 1\n",
      "  Heimler: 1\n",
      "  radio-digito-facial: 1\n",
      "  cono-spondylar: 1\n",
      "  NR1I3: 1\n",
      "  spherocytosis: 1\n",
      "  SOD1: 1\n",
      "  Oxybutynin: 1\n",
      "  maculopapular: 1\n",
      "  Saquinavir: 1\n",
      "  Moebius: 1\n",
      "  SLC2A2: 1\n",
      "  chondrodysplasia-pseudohermaphroditism: 1\n",
      "  otopalatodigital: 1\n",
      "  3M: 1\n",
      "  branched-chain: 1\n",
      "  Pfeiffer: 1\n",
      "  Triazolam: 1\n",
      "  AK2: 1\n",
      "  Tel: 1\n",
      "  KCNK4: 1\n",
      "  AKR7A3: 1\n",
      "  Aminoglutethimide: 1\n",
      "  striatal: 1\n",
      "  hyperimmunoglobulinemia: 1\n",
      "  STAC3: 1\n",
      "  Bisoprolol: 1\n",
      "  Carvedilol: 1\n",
      "  Capreomycin: 1\n",
      "  paramyotonia: 1\n",
      "  Roxithromycin: 1\n",
      "  Rapid: 1\n",
      "  CLOVES: 1\n",
      "  Clarithromycin: 1\n",
      "  Misoprostol: 1\n",
      "  McLeod: 1\n",
      "  dumping: 1\n",
      "  Faye-Petersen-Ward-Carey: 1\n",
      "  hemophilia: 1\n",
      "  MPDU1-CDG: 1\n",
      "  Fuchs: 1\n",
      "  Methyltestosterone: 1\n",
      "  Medial: 1\n",
      "  BDNF: 1\n",
      "  KANSL1: 1\n",
      "  BAK1: 1\n",
      "  agonadism,: 1\n",
      "  spondyloperipheral: 1\n",
      "  osteoid: 1\n",
      "  oculo: 1\n",
      "  Cogan: 1\n",
      "  Donnai-Barrow: 1\n",
      "  KCNN3: 1\n",
      "  Unverricht-Lundborg: 1\n",
      "  scalp-ear-nipple: 1\n",
      "  Calcification: 1\n",
      "  Kahrizi: 1\n",
      "  Nizon-Isidor: 1\n",
      "  MIRAGE: 1\n",
      "  HELIX: 1\n",
      "  galactokinase: 1\n",
      "  CDH1: 1\n",
      "  USH1G: 1\n",
      "  glycosylphosphatidylinositol: 1\n",
      "  COFS: 1\n",
      "  Gomez-Lopez-Hernandez: 1\n",
      "  mucus: 1\n",
      "  Oral: 1\n",
      "  Global: 1\n",
      "  apert: 1\n",
      "  aspartylglucosaminuria: 1\n",
      "  Hydrochlorothiazide: 1\n",
      "  gamma-heavy: 1\n",
      "  Endocardial: 1\n",
      "  robinow: 1\n",
      "  pterygium: 1\n",
      "  leishmaniasis: 1\n",
      "  Rhinitis: 1\n",
      "  Ropinirole: 1\n",
      "  hypoparathyroidism: 1\n",
      "  acyl-CoA: 1\n",
      "  lymphoproliferative: 1\n",
      "  grix: 1\n",
      "  deafness-small: 1\n",
      "  saccharopinuria: 1\n",
      "  bilirubin: 1\n",
      "  IDUA: 1\n",
      "  Lisuride: 1\n",
      "  ADNP-related: 1\n",
      "  Restless: 1\n",
      "  LRTOMT: 1\n",
      "  narcolepsy: 1\n",
      "  NSD2: 1\n",
      "  brachyphalangy,: 1\n",
      "  gastrocutaneous: 1\n",
      "  fine-Lubinsky: 1\n",
      "  SLC26A4: 1\n",
      "  circumvallate: 1\n",
      "  Steel: 1\n",
      "  Natamycin: 1\n",
      "  graft: 1\n",
      "  thymus: 1\n",
      "  hypocomplementemic: 1\n",
      "  Decitabine: 1\n",
      "  horizontal: 1\n",
      "  blood: 1\n",
      "  Ibandronate: 1\n",
      "  Bencze: 1\n",
      "  creatine: 1\n",
      "  signaling: 1\n",
      "  rhiny: 1\n",
      "  PIGP: 1\n",
      "  COPS3: 1\n",
      "  mu-heavy: 1\n",
      "  leukemia,: 1\n",
      "  CACNA1D: 1\n",
      "  Specific: 1\n",
      "  Diclofenac: 1\n",
      "  Marshall: 1\n",
      "  Paget: 1\n",
      "  Wernicke-Korsakoff: 1\n",
      "  Articaine: 1\n",
      "  hantavirus: 1\n",
      "  extracellular: 1\n",
      "  angel-shaped: 1\n",
      "  Holzgreve-Wagner-Rehder: 1\n",
      "  Dysarthria: 1\n",
      "  CHRNB2: 1\n",
      "  diaphanospondylodysostosis: 1\n",
      "  dysplastic: 1\n",
      "  hyperinsulinism-hyperammonemia: 1\n",
      "  thumbs,: 1\n",
      "  Keratan: 1\n",
      "  Kilquist: 1\n",
      "  asternia: 1\n",
      "  Bosentan: 1\n",
      "  RPS6KA3: 1\n",
      "  Chiari: 1\n",
      "  Potter: 1\n",
      "  binder: 1\n",
      "  piebald: 1\n",
      "  guanidinoacetate: 1\n",
      "  dysmorphism-pectus: 1\n",
      "  TMTC2: 1\n",
      "  erythrokeratodermia: 1\n",
      "  Young: 1\n",
      "  NDE1-related: 1\n",
      "  TMEM199-CDG: 1\n",
      "  Impairment: 1\n",
      "  Esomeprazole: 1\n",
      "  genochondromatosis: 1\n",
      "  Asymmetric: 1\n",
      "  LEOPARD: 1\n",
      "  coxopodopatellar: 1\n",
      "  Cabergoline: 1\n",
      "  IMAGe: 1\n",
      "  aspergillosis: 1\n",
      "  His: 1\n",
      "  allain-babin-demarquez: 1\n",
      "  Nafarelin: 1\n",
      "  cystinuria: 1\n",
      "  Cefaclor: 1\n",
      "  17q11.2: 1\n",
      "  MPP3: 1\n",
      "  ILDR1: 1\n",
      "  endosteal: 1\n",
      "  pelviscapular: 1\n",
      "  Esmolol: 1\n",
      "  internal: 1\n",
      "  Estrone: 1\n",
      "  mucopolysaccharidosis-like: 1\n",
      "  aregenerative: 1\n",
      "  atelosteogenesis: 1\n",
      "  Takayasu: 1\n",
      "  substance: 1\n",
      "  mild: 1\n",
      "  atonic-astatic: 1\n",
      "  Primidone: 1\n",
      "  Lidocaine: 1\n",
      "  Wolf-Hirschhorn: 1\n",
      "  NR5A2: 1\n",
      "  transketolase: 1\n",
      "  trichomegaly: 1\n",
      "  branchiootorenal: 1\n",
      "  thumb,: 1\n",
      "  WHRN: 1\n",
      "  Nance-Horan: 1\n",
      "  Flaring: 1\n",
      "  FRAXE: 1\n",
      "  Barnicoat: 1\n",
      "  Lumbar: 1\n",
      "  hypophosphatemia,: 1\n",
      "  AMED: 1\n",
      "  cardiomyopathy-hypotonia-lactic: 1\n",
      "  myasthenia: 1\n",
      "  PDA1: 1\n",
      "  ventriculomegaly: 1\n",
      "  myopia,: 1\n",
      "  Hennekam-Beemer: 1\n",
      "  Mefenamic: 1\n",
      "  microcephaly-cervical: 1\n",
      "  sitosterolemia: 1\n",
      "  obesity,: 1\n",
      "  IFT80: 1\n",
      "  myoclonic-atonic: 1\n",
      "  PA: 1\n",
      "  glucagonoma: 1\n",
      "  neurohypophyseal: 1\n",
      "  DIAPH1: 1\n",
      "  ichthyosis-cheek-eyebrow: 1\n",
      "  COG1-CDG: 1\n",
      "  GDNF: 1\n",
      "  leptospirosis: 1\n"
     ]
    }
   ],
   "source": [
    "# Summarize node types connected to Hurler syndrome\n",
    "node_types = defaultdict(int)\n",
    "for n, data in H.nodes(data=True):\n",
    "    if isinstance(n, str):\n",
    "        node_types[n.split()[0]] += 1\n",
    "\n",
    "print(\"[INFO] Node type distribution in subgraph:\")\n",
    "for k,v in node_types.items():\n",
    "    print(f\"  {k}: {v}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "31a921d5",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 900x900 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import networkx as nx\n",
    "\n",
    "plt.figure(figsize=(9,9))\n",
    "# Put the main disease node in the center\n",
    "center_node = \"Hurler syndrome\"\n",
    "pos = nx.shell_layout(H, nlist=[[center_node], list(set(H.nodes())-{center_node})])\n",
    "\n",
    "nx.draw_networkx_nodes(H, pos, node_size=70, node_color=\"lightcoral\")\n",
    "nx.draw_networkx_edges(H, pos, alpha=0.3)\n",
    "nx.draw_networkx_labels(H, pos, font_size=6)\n",
    "plt.title(\"Hurler Syndrome Radial Subgraph\")\n",
    "plt.axis(\"off\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "af9e3b2e",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[INFO] Drug associations for Hurler syndrome:\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>x_name</th>\n",
       "      <th>y_name</th>\n",
       "      <th>relation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5775910</th>\n",
       "      <td>Hurler syndrome</td>\n",
       "      <td>Laronidase</td>\n",
       "      <td>indication</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                  x_name      y_name    relation\n",
       "5775910  Hurler syndrome  Laronidase  indication"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Extract drug connections\n",
    "drug_edges = hurler_rows[hurler_rows['y_type'].str.contains(\"drug\", case=False, na=False)]\n",
    "if len(drug_edges) == 0:\n",
    "    drug_edges = hurler_rows[hurler_rows['x_type'].str.contains(\"drug\", case=False, na=False)]\n",
    "\n",
    "print(\"[INFO] Drug associations for Hurler syndrome:\")\n",
    "drug_edges[['x_name','y_name','relation']].drop_duplicates().head(20)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
